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Sox4 es un factor de transcripción perteneciente a la clase SoxC (que engloba a 
Sox4, Sox11 y Sox12), dentro de la superfamilia de proteínas relacionadas con Sry con 
dominios tipo HMG. 
La expresión de Sox4 es máxima durante el desarrollo embrionario en la cresta 
neural y el mesénquima, donde regula la diferenciación y desarrollo de precursores 
neuronales y mesenquimales. Así mismo, también se ha detectado expresión de Sox4  
en otros tejidos como timo, bazo, páncreas y folículos pilosos. 
Durante la embriogénesis, Sox4 está implicado en un vasto panel de procesos 
que incluyen maduración de linfocitos B y T, modulación de la diferenciación mieloide, 
desarrollo de islotes pancreáticos y osteoblastos, y adecuada formación del canal 
auriculoventricular. Ratones deficientes en la expresión de Sox4 presentan letalidad 
embrionaria debido a profundas malformaciones cardíacas, que cursan con defectos en 
hematopoyesis y en la formación de islotes pancreáticos. 
En adultos la expresión de Sox4 se restringe a unos pocos tejidos como la médula 
ósea, sistema reproductivo femenino, criptas intestinales, islotes pancreáticos y folículos 
pilosos activados. Dichas constricciones son sugestivas de una fuerte regulación que 
asegure una adecuada homeostasis tisular; de hecho, la desregulación de la expresión 
de Sox4 en adultos se encuentra asociada a transformación celular. 
Sox4 puede actuar como un potente oncogén que promueve la supervivencia de 
células transformadas y favorece el crecimiento independiente de anclaje a substrato. La 
expresión elevada de Sox4 está estrechamente asociada a leukemogenesis, inhibición de 
la apoptosis y aumento de la viabilidad celular. Además, el aumento de la expresión de 
Sox4 se asocia frecuentemente a la adquisición de un fenotipo invasivo dado a que es 
capaz de promover el programa transcripcional asociado a la EMT, y por lo tanto a 
menudo se asocial a la colonización metastática de tejidos distantes. 
Para estudiar Sox4 en adultos, hemos generado ratones con niveles reducidos de 
Sox4 en todo el organismo. Dichos ratones muestran un panel de enfermedades 
asociadas al envejecimiento y resistencia frente al cáncer espontáneo, indicando un 
papel para Sox4 en el mantenimiento de la homeostasis tisular y en tumorogénesis. Para 
estudiar en detalle el papel de Sox4 en células madre adultas, hemos delecionado Sox4 
de forma condicional en epitelio estratificado (ratones Sox4cKO). Estos ratones muestran 
mayor quiescencia en las células madre de la piel junto a una mayor acumulación de 
daño en el DNA y resistencia a carcinogénesis química. Dichos fenotipos correlacionan 
con una regulación negativa de genes implicados en ciclo celular, reparación de daño en 
el DNA y diferenciación de células madre de la piel. Estos resultados resaltan la 
importancia de Sox4 en la homeostasis tisular adulta y cáncer. 
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Julio Cortázar. Rayuela, Cap. 137 

Abstract 
 
 
 XIII
 
Sox4 belongs to the SoxC class of transcription factors (encompassing Sox4, 
Sox11 and Sox12) within the Sry-related HMG box-containing superfamily of proteins.  
Sox4 expression peaks during embryonic development in neural crest and 
mesenchyme, where it regulates the differentiation and survival of mesenchymal and 
neural progenitors. Sox4 expression has also been found in thymus, spleen, developing 
pancreas and hair follicles. During embryogenesis, Sox4 has been implicated in a plethora 
of processes including the maturation of B and T lymphocytes, the modulation of myeloid 
differentiation, pancreatic islet development, osteoblast development and proper cardiac 
cushion formation. Sox4-/- mice display embryonic lethality at E14.5, mainly due to 
profound cardiac malformations, concomitant with defective haematopoiesis and 
pancreatic islet formation defects.  
In adults, the Sox4 is restricted to few tissues such as haematopoietic 
compartment, female reproductive system, intestinal crypts, pancreatic islets and 
activated hair follicles. These constrictions suggest a tight regulation to ensure proper 
tissue homeostasis; indeed, deregulated Sox4 expression is frequently associated to 
malignant cellular transformation. 
Sox4 can act as a potent oncogene that promotes the survival of transformed cells 
and favours anchorage-independent cell growth and motility. High expression of Sox4 is 
associated with leukemogenesis, inhibition of apoptosis and increased cell viability. 
Moreover, increased Sox4 expression is often linked to the acquisition of an invasive 
phenotype by promoting the initiation of the EMT transcriptional program, and therefore is 
often associated to metastatic colonization of distant tissues. 
To study the role of Sox4 in the adult organism, we first generated mice with 
reduced whole-body Sox4 expression. These mice display a plethora of age-related 
degenerative disorders and reduced spontaneous cancer incidence, indicating a role for 
this protein in maintaining adult tissue homeostasis and in tumour growth. To specifically 
address a role for Sox4 in adult stem cells, we conditionally deleted Sox4 (Sox4cKO) in 
stratified epithelia. Sox4cKO mice show increased skin stem cell quiescence and DNA 
damage accumulation, accompanied by resistance to chemical carcinogenesis. These 
phenotypes correlate with downregulation of cell cycle, DNA repair and skin stem cell 
differentiation genes. Altogether, our findings highlight the importance of Sox4 in adult 
tissue homeostasis and cancer. 
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EMT  Epithelial to mesenchymal transition 
EtOH  Ethanol 
ES  Enrichment score 
FBS  Foetal bovine serum 
FDR  False discovery rate 
GFP  Green fluorescent protein 
GSEA  Gene set enrichment analysis 
HCC  Hepatocellular carcinoma 
HSCs  Haematopoietic stem cells 
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HET  Heterozygous 
HFSC  Hair follicle stem cell 
HMG  High mobility group 
HT-QFISH  High-throughput quantitative fluorescence in-situ hybridization 
iPS Induced pluripotent stem 
IRES  Internal ribosome entry site 
IFE  Interfollicular epidermis 
JZ  Junctional zone 
K5  Keratin5 promoter 
KI  Knock-In 
KO, cKO  Knock-Out, conditional Knock-Out 
KSR  Knockout serum replacement 
LIF  Leukemia-inhibiting factor 
MEF  Mouse embryo fibroblast 
MET  Mesenchymal to epithelial transition 
mES  Mouse embryonic stem 
min  minute(s) 
miRNA,miR  micro-RNA 
PBS  Phosphate buffer saline 
PCR  Polymerase chain reaction 
qPCR  Quantitative-Real Time PCR 
PNA  Peptide nucleic acid 
PFA  Paraformaldehyde 
PTH Parathyroid hormone 
RA  Retinoic acid 
RIS  Retroviral integration site 
ROI  Region of interest 
RS  Replicative stress 
RT  Room temperature 
sec  second(s) 
siRNA  small-interference RNA 
shRNA  short-hairpin RNA 
SG  Sebaceous gland 
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SDS-PAGE  Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
ssDNA  single-stranded DNA 
Sry  Sex-determining region of the Y chromosome 
Sox  Sry-related, HMG box-containing protein 
T2D  Type 2 diabetes 
Terc  Telomerase RNA component 
TERT  Telomere end repeat retrotranscriptase 
Tg  Transgenic 
TPA  12-O-Tetradecanoylphorbol-13-acetate 
TRF1  Telomere end repeat binding factor 1 
UTR  Untranslated region 
UV  Ultra-Violet light 
WT  wild type 
XEN  Extraembryonic endoderm 
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I. DEVELOPMENT, CANCER AND AGEING 
 
Mammalian embryonic development comprises a plethora of tightly regulated 
biological processes (spatiotemporal control of specific gene regulation, cell signalling, cell 
migration and growth, tissue patterning and modulation of metabolism among others) that 
govern the differentiation of the embryonic stem cells into all the cellular lineages that form 
the adult organism while maintaining a population of undifferentiated cells that ensure 
proper input to all cellular lineages (Tam and Loebel 2007; Smith, 2001). Likewise, adult 
organs and tissues are maintained through a delicate balance of proliferation, 
differentiation and self-renewal of their tissue-type adult stem cells in order to keep a 
constant replacement of the damaged cells originated upon injury or during normal tissue 
homeostasis (Wagers and Weissman, 2004; Blanpain and Simons, 2013). Any 
perturbation in the aforementioned control of such regulatory mechanisms can cause 
aberrant loss or gain of cellular fitness. On one hand, accumulation of cellular damage is 
thought to be the widest accepted cause of ageing (Lopez-Otin et al, 2013); on the other 
hand, aberrant proliferative potential or increased survival advantage are some of the 
commonest hallmarks of cancer (Hanahan and Weinberg, 2011). 
 
 
II. THE MAMMALIAN SKIN AS A MODEL FOR STEM CELL FUNCTION 
 
The skin is the largest of the mammalian organs and its main function consists on 
covering the entire body surface in order to provide protection from external aggressions 
(either from biological or from physical sources, such as infections or ionizing radiations, 
respectively) and to confer a barrier against water loss and thereby prevent dehydration. It 
also provides an additional layer of functionality with its multiple specialised appendages, 
such as touch pads for sensing, sweat glands for thermoregulation and excretion, feathers 
and hairs for thermal isolation and defensive keratinized structures (Fuchs, 2007). The 
skin structure meets the functional requirements of such a specialised organ, and its 
repertoire of specialised cell populations and their dynamics in mammals have been 
broadly studied; this knowledge provides a great tool in cell biology for addressing 
embryonic and adult stem cell function during development, ageing, regeneration and 
cancer (Arwert et al., 2012; Blanpain and Fuchs, 2009). 
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II.1. The structure of the mammalian skin 
 
In mammals, the skin is composed of the dermis and the epidermis. The dermis is 
a supportive connective tissue which contains fibroblasts and a dense scaffold composed 
of collagen, elastin and glucosaminoglycans, that is placed on top of a subcutaneous fat 
pad covering the muscular layer. The epidermis is the external layer, and is attached to 
the dermis through the basement membrane (BM). The epidermis comprises several 
layers of differentiating keratinocytes, remaining the less differentiated ones directly 
attached to the BM (Watt and Huck, 2013). The increased differentiation towards the 
surface is accompanied by programmed cell death (apoptosis), cornification 
(accumulation of intermediate filaments, especially keratins, in the cytosol), stratification 
and sequential expression of differentiation markers (cytokeratin 14 in the basal layer, 
cytokeratin 10 in the suprabasal or spinous layer, involucrin and filaggrin in the granular 
layer and loricrin in the cornified layer) (Fuchs, 1994). 
Being the most exposed part of the skin, the epidermis is subjected to constant 
mechanical tension and other types of physicochemical aggressions. In order to prevent 
the tearing of the skin with such stresses, the epidermal keratinocytes are subjected to 
constant replacement. The source of this replacement is the basal layer of the epidermis, 
which proliferates constantly in order to provide with fresh cells the upper epidermal 
layers, while the cornified, dead cells are constantly desquamated and shed from the skin 
surface. Similarly, most other epidermal structures are constantly renewed through 
recurring bouts of proliferation, differentiation and degeneration that take place during the 
hair cycle, and which depends on the timely activation of the so-called hair follicle stem 
cells (HFSCs), which provide with their input to all the skin cellular lineages (Alonso and 
Fuchs, 2006; Fuchs, 2007).  
 
 
II.2. The hair follicle and the hair cycle 
 
The outermost part of the mammalian epidermis is composed of a multi-layered 
epithelium known as the Interfollicular Epidermis (IFE) and its adjunct structures: hair 
follicles (HFs), sebaceous glands (SGs) and sweat glands (SwGs). In mice, the sweat 
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glands are restricted to hairless regions, such as the paws; therefore, the epidermal stem 
cell potential is usually assessed in terms of input to the IFE, the HF and the SG. 
Terminally-differentiated cells from these compartments are constantly lost and thus it has 
been long known that all the epidermal lineages are maintained by the HFSCs, capable of 
self-renewal and terminal differentiation (Blanpain and Fuchs, 2006). 
Every hair is destroyed and regenerated several times during an organism 
lifespan, initially in a synchronic manner that gradually becomes less frequent and less 
coordinated among different parts of the body with ageing. The hair cycle in mice has 
been deeply characterised, mostly because of its structural resemblance with that of 
human hair cycle and because it provides an unvaluable tool for modelling adult stem cell 
function. In fact, each hair follicle is considered to be a mini organ, composed of 
specialised structures containing differentiated cells and a variety of multipotent stem cells 
(the HFSCs) that can partially (or totally, under certain circumstances such as wound 
repair) regenerate the whole hair structure (Blanpain and Fuchs, 2009).  
 
 
Figure 1. The Hair cycle. Adapted f rom Alonso and Fuchs, 2006. 
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The hair cycle is composed of three alternating states, namely the resting phase or 
telogen (from the Greek telos: end, completion, perfection), proliferative phase or anagen 
(from the Greek ana: up, upward, anew) and the destructive phase or catagen (from the 
Greek kata: downward, regression) (Figure 1). After each cycle, the old hair is lost and a 
new complete fur coat is generated from the hair follicle stem cells (HFSCs) (Alonso and 
Fuchs, 2006). Every cycle happens in waves that start at the snout and progresses along 
the mouse back towards the tail, and each of the stages of the hair cycle have been 
meticulously studied and can therefore be identified through detailed 
inmunohistochemistry (Muller-Rover et al., 2001). The alternation between these states is 
orchestrated by the dermal papilla, which provides the appropriate signals required for 
HFSC activation mainly through the TGFβ, Shh and Wnt/β-catenin pathways (Oshimori 
and Fuchs 2012; Kobielak et al., 2007; Watt et al. 2008).  In mammals, HFSCs reside 
mainly at the Junctional Zone and Hair bulge regions (Figure 1). The molecular signature 
of resting and activated HFSC has been extensively studied by transcriptional profiling, 
showing that while dormant HFSCs are enriched in factors that promote quiescence 
and/or self-renewal including Lhx2, Lgr5, Lgr6, Lrig1 and CD34 among others (Braun et 
al., 2003; Jaks et al., 2008; Jensen et al., 2009; Jensen et al., 2010; Nowak et al., 2008; 
Rhee et al., 2006; Snippert et al., 2010; Tumbar et al., 2004), activation of HFSC occurs 
stepwise with increased expression of genes involved in cell cycle progression, 
extracellular matrix/adhesion and transcription (Greco et al., 2009). Among them, Sox4 
(Sry-related High Mobility Group (HMG) box-containing transcription factor 4) has been 
found upregulated upon hair regeneration cues (Greco et al., 2009; Kobielak et al., 2007; 
Lien et al., 2014; Lowry et al., 2005). 
 
 
III. THE HIGH-MOBILITY GROUP SUPERFAMILY 
 
The Sox4 gene belongs to the SoxC class within the Sox family of transcription 
factors. All Sox proteins share a High-mobility-group (HMG), a functional domain also 
found in other members of the HMG domain superfamily. To get a better insight into the 
major roles of Sox4 it becomes indispensable to have first an overview to the history of its 
discovery, its family diversification and finally a brief description of its functional domain 
organization. We finally brief the main functions assigned to Sox4 in development and 
cancer. 
 
Introduction 
 
 19
Th Sp
HMG domain
(HMGB)
AT-Hook
(HMGA)
Nucleosome-
binding
(HMGN)
TCF/
LEFSox
HMG-containing proteins
HMGN1, HMGN2, HMGN3... HMGA1a, HMGA1b, HMGA2
SoxA, SoxB, 
SoxC...
HMGB1, TCF4,
LEF1...
A
C
B
Figure 2. The HMG domain superfamily
(A) Polyacrilamide gel elctrophoresis showing HMG proteins isolated f rom mouse thymus (Th) or spleen (Sp). Adapted 
f rom Rabbani, 1978. 
(B) Diversity of  HMG-containing proteins.
(C) Schematic representation of  two HMG-box domains f rom LEF-1, either alone or in complex with a DNA molecule. 
Source: Biochemical Society Transactions.
 
 
III.1. The discovery of the High-mobility-group (HMG) domain proteins 
 
In the early 1970’s the search for non-histone DNA-bound proteins led to the 
discovery of an intriguing group of proteins which clustered together when analysed by 
SDS-PAGE according to their mobility in acrylamide gels (Goodwin et al., 1973). This 
group of proteins belonged to three unrelated families of DNA-bound proteins: the 
nucleosome-binding family (also known as HMG-14/17), the AT-hook family (or HMG-Y) 
and the HMG domain family (or HMG-1/2). Proteins containing an HMG domain (also 
known as HMG-box) comprise the T-cell factor (TCF)/lymphoid enhancer binding factor 
(LEF) family and the Sox family (Figure 2). HMG-box proteins have acquired certain 
sequence specificity in the binding to DNA that the rest of HMG-containing proteins lack. 
Moreover, and in contrast to other HMG domain members, HMG-box factors are 
expressed at very low levels in a limited subset of cell types, suggesting a tight regulation 
and functional diversification (Harley and Lefebvre, 2009). 
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Table 1. Sox family members. Adapted f rom Lefebvre et al 2007, and Sarkar et al 2013
Class Members Expression Function
SoxA Sry Male germ cells Male sex determination
Sox1 Neural Progenitor Cells (NPCs) NPC specification and maintenance
Sox2 Ectoderm, endoderm and mesoderm derivatives Embryonic/adult stem cell specification and maintenance
Sox3 Spermatogonia, NPCs
Spermatogonia differentiation, NPC specification and 
maintenance
Sox14 Neural tube, limbic ectodermal ridge Neuronal differentiation, limb development
Sox21 NPCs Neuronal differentiation
Sox4 NPCs, mesenchymal stem cells, haematopoietic 
system, pancreas, kidney, heart, uterus, skin...
B/T cell specification, regulation of survival/apoptosis, cardiac 
development, osteoblast/myeloid/β-cell differentiation
Sox11 NPCs, heart, pancreas, haematopoietic system, 
lymphoid differentiation, cardiac development, osteoblast 
differentiation, neurogenesis
Sox12 Cardiac progenitors, NPCs, mesenchymal 
progenitors
Cardiac development, neural development
Sox5 NPCs, bone Neurogenesis, skeletogenesis
Sox6 Mesoderm Cardiac development, skeletogenesis, erythropoiesis
Sox13 T lymphocytes Lymphoid differentiation
Sox8 Muscle satellite cells Inhibition of myogenesis
Sox9
Hair follicle stem cells, NPCs, distal tip cells 
(lung), pancreatic progenitors, liver duct cells, 
intestinal progenitors, mammary stem cells
Stem cell specification and maintenance
Sox10 NPCs, melanocyte Stem cell maintenance, melanocytic lineage determination
Sox7
Cardiac progenitors, haemogenic endothelium, 
HSCs Cardiogenesis, erythropoiesis
Sox17 Extraembryonic endoderm (XEN), haematopoiteic 
stem cells
XEN gene expression regulation, fetal HSC maintenance
Sox18 Cardiac progenitors, haemogenic endothelium, 
hair follicles
Cardiogenesis, angiogenesis, hair follicle development
SoxG Sox15 ES cells, satellite cells No obvious phenotype from LOF
SoxH Sox30 Unknown NA
SoxB1
SoxF
SoxD
SoxE
SoxB2
SoxC
 
 
III.2. The Sox family portrait 
 
In the early 90’s the search for an elusive male-determining differentiation factor 
finished when Dr. A. H. Sinclair and colleagues discovered Sry (acronym for Sex-
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determining region of the Y chromosome), the founding member of the Sox family 
(Sinclair et al., 1990). After the discovery of Sry, an intense research activity focused on 
finding proteins with high degree of identity with this factor, and this lead to the 
identification of several Sry-related genes with important functions in sex determination, 
development and adult/embryonic stem cell function (Lefebvre et al., 2007; Sarkar and 
Hochedlinger, 2013). For classification purposes, only genes sharing at least 50% 
homology with the HMG domain from Sry were included in the Sox family. 
In mammals there are twenty Sox factors classified into nine groups (SoxA, 
SoxB1, SoxB2, SoxC, SoxD, SoxE, SoxF, SoxG and SoxH; see Table 1), according to 
their protein sequence homology (Harley and Lefebvre, 2009). Each of them regulates 
diverse aspects related to adult stem cell function and cell fate decissions, nuclear 
reprogramming to induced pluripotency (generation of iPS cells), cell specification, 
differentiation and numerous crucial steps of embryonic development (Sarkar and 
Hochedlinger, 2013). Members from the same group share a high degree of identity along 
its whole aminoacidic sequence, whereas members from different groups share up to 50% 
homology in the HMG box domain, by definition, and none in the rest of the protein 
sequence (Bowles et al., 2000). 
 
 
III.3. The structure of Sox proteins 
 
All Sox factors share a HMG box, and most of them display several other domains 
which confer them additional properties such as oligomerization, subcellular localization, 
transactivation or sequence specificity modulation.  
The HMG-box domain features three L-shaped α-helices that allow the HMG-box 
bind and bend the minor groove of the DNA; this sharp curvature induces a local shift in 
the chromatin conformation, thereby enabling the assembly of transcriptional activator 
complexes and subsequent transactivation of gene expression (Figure 2). Besides its role 
in transactivation (including DNA recognition, and bending), the HMG-box fulfils other 
basic functions required for the proper functioning of Sox proteins, including nuclear 
translocation and protein-protein interaction (Lefebvre et al., 2007). DNA motif recognition 
specificity was studied by in vitro DNA site selection assays, which unveiled a preference 
for the hexameric sequence 5’-WWCAAW-3’ (where W stands for either A or T). In the 
case of Sox4, its crystal structure has been recently solved in complex with DNA, and this 
revealed slight structural differences with other Sox members, such as Sox2 or Sox17 
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(Jauch et al., 2012). In particular, Sox4 can accommodate a primary AACAAG and a 
secondary AATTGTT motif. Despite these sequence preferences, the HMG-box of Sox 
proteins displays a very low affinity and a variable sequence specificity, as seen for 
example in the degree of variability with respect to the consensus sequence that Sox4 
shows in some of its bound enhancer sequences, such as the ones belonging to Tubb3 
(TATTGTC, CATTGTG), CD2 (AACAATA) or Tead2 (CTTTGTC, CTTTGTT) genes. 
Therefore, given the low specificity in target recognition and the widespread distribution of 
consensus sequences along the genome, it remains challenging in general to identify 
HMG-box recognised sequences and makes it impossible to predict Sox-target sequences 
based solely on the presence of matching motifs, in contrast to most of the rest of 
mammalian transcription factors (Lefebvre et al., 2007; Vervoort et al., 2013b). 
In the case of Sox4, its protein structure also features a transactivation domain 
(TAD) whose main function is to activate Sox4 transcriptional activity functions through yet 
unknown mechanisms. The TAD domain is adjacent to a destruction domain (DD) 
necessary for regulating the protein stability and proteasomal-dependent degradation, a 
glicine-rich region (GRR) required for the regulation of Sox4-mediated apoptosis, a serine-
rich region with not very well characterised functions (SRR) (Figure 3) (Vervoort et al., 
2013b). 
 
 
PP PPP P P PAAAA A
HMG-box GRR SRR TAD/DD
1 59 135 152 227 333 397 441 474
Brn1, p53, 
Syntenin-1, 
GATA3
Ubc9, p53, 
Syntenin-1, GATA3, 
Tbc3
Other interaction partners: TCF4, β-catenin, 
p300, Plakoglobin, Oct4
Figure 3. Functional domain organization, interacting proteins and post-translational modifications  of Sox4. 
P, phosphorylation; A, acetylation; GRR, Glicine-rich; SRR, Serine-rich; TADD/DD, transactivation domain/degradation 
domain; numbers stand for aminoacid position. Adapted from Vervorrt et al, 2013.  
 
 
IV. SOX4 IN EMBRYONIC DEVELOPMENT 
 
Sox4 belongs to the SoxC class of transcription factors, encompassing Sox4, 
Sox11 and Sox12 (Harley and Lefebvre, 2010). As mentioned above, Sox4 specificity in 
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target recognition largely depends on cellular and molecular contexts when binding to 
different target promoters and enhancers (Jauch et al., 2012). Sox4 is expressed mainly 
during embryonic development in neural crest and mesenchyme, and displays a high 
degree of overlapping in most tissues with its cousin members Sox11 and Sox12 (Dy et 
al., 2008). Sox4 mRNA has also been detected in the developing pancreas, thymus, 
spleen and hair follicles (Dy et al., 2008; Hoser et al., 2008; Lioubinski et al., 2003). Most 
of the functions of Sox4 have been ascertained from the study of mouse models with 
deficient expression of either Sox4 alone or in combination with other SoxC class 
members. Sox4-null mice die at midgestation (E14.5) due to profound cardiac 
malformations, unveiling a role for Sox4 in cardiac outflow formation (Paul et al., 2013; 
Schilham et al., 1996). Other functions attributed to Sox4 are the regulation of survival and 
proliferation of neural and mesenchymal progenitors, where its expression peaks in 
coordination with Sox11 and Sox12 to ensure the survival and proliferation of neural 
progenitor cells (NPCs) (Bhattaram et al., 2010). Of note, part of the late embryonic 
lethality seen in Sox4-/- mice is at least partially due to the strong overlap among all SoxC 
class members, a fact that is evident upon simultaneous knock-out of both Sox4, Sox11 
and Sox12, which results in accelerated embryonic lethality (E8) than with either of the 
single knock-out mice (Bhattaram et al., 2010). Sox4 also intervenes in  pancreas 
development, as Sox4-/- mice display reduced pancreatic islet formation capacities, 
resulting in impaired insulin secretion and glucose tolerance (Wilson et al., 2005). 
Moreover, Sox4+/- mice show diminished bone formation and osteoblast developmental 
defects, an effect related to parathyroid hormone signalling defects observed in 
osteoblasts (Nissen-Meyer et al., 2007). B and T cell maturation defects have been 
observed in haematopoietic progenitors obtained from Sox4-/- embryos and Sox4 is 
induced during TGFβ-mediated differentiation of Th2 lymphocytes (Kuwahara et al., 2012; 
Laurenti et al., 2013; Schilham et al., 1997; Schilham et al., 1996). Moreover, Sox4 is 
involved in the regulation of myeloid differentiation, a feature often involved in the onset of 
myeloid leukemia (see below), by regulating IL5-triggered myelopoiesis, (Aue et al., 2011; 
Geijsen et al., 2001; Sandoval et al., 2012).  
In adults, Sox4 expression is found in a limited set of tissues such as female 
reproductive system, hematopoietic system, pancreatic islets, intestinal crypts and 
activated Hair Follicle Stem Cells (HFSCs) (Deneault et al., 2009; Hunt and Clarke, 1999; 
Lien et al., 2014; Schilham et al., 1997; Van der Flier et al., 2007; Wilson et al., 2005). 
These constrictions in expression of Sox4 by adult cells suggest a tight regulation required 
to maintain an adequate tissue homeostasis. Indeed, aberrant Sox4 expression in adult 
tissues has been linked to cancer onset and progression in mice and humans (Jafarnejad 
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et al., 2013a; Vervoort et al., 2013b). Some of the most relevant cellular functions of Sox4 
have been unveiled by studying its involvement in cancer onset and progression, 
therefore they will be discussed in closer detail in the next section. 
 
 
V. ROLES OF SOX4 IN CANCER ONSET AND PROGRESSION 
 
It is widely accepted that given I) their prominent roles in regulating crucial cell-fate 
decisions along embryonic development and II) the tight spatiotemporal regulation of Sox 
protein expression levels, uncontrolled expression of these factors during the adulthood 
leads to loss of cell identity and cancer in general terms. Sox4 is no exception in this 
regard. There are however few cases in which Sox4 has been reported as a potential 
tumour suppressor, due to its positive correlation with induction of apoptosis immediately 
upon Sox4 overexpression; nevertheless, it is not completely clear whether these are in 
fact autonomous mechanisms triggered by the cell upon oncogenic traits in order to 
prevent transformation as it is the case of the oncogene c-Myc (Jafarnejad et al., 2013a; 
Vervoort et al., 2013b). The case of melanoma, in which Sox4 seems to behave 
specifically as a tumour suppressor, will be discussed in detail (see below).  
 
 
V.1. Sox4 in blood malignancies 
 
The first proof that Sox4 could act as an oncogene in vivo was the finding of the 
Sox4 locus as one of the most common integration sites in genome-wide tagging 
protocols based on retroviral-mediated activation of proto-oncogenes. In two inbred 
mouse models bearing random retroviral insertion-mediated gene activation that led to 
myeloid or B-/T-cell leukemia (BHX-2 mice  and AKXD mice, respectively), a high-
throughput screening based on inverse PCR sequencing revealed retroviral integration 
sites (RISs) relevant for cancer and unknown thus far. From a group of B-cell lymphomas 
from the AKXD strain, a panel of RISs was isolated; interestingly, the authors of the study 
also found these RIS in myeloid leukaemia samples obtained from the BHX-2 strain. 
Being these RISs found repeatedly enriched in tumours of different origin vs. normal 
tissue, they were referred to as CISs, common integration sites; these CIS therefore 
tagged new genes potentially involved in cancer (Suzuki et al., 2002) (Figure 4). Sox4 was 
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one of the factors whose promoter was most frequently targeted, and in subsequent 
studies reproducing retroviral tagging experiments with replication-incompetent, LT-
expressing retroviruses, this finding was validated in a number of independent studies (Du 
et al., 2005; Li et al., 2007; Shin et al., 2004), indicating that Sox4 behaves as an 
oncogene in haematological tumours such as myeloid leukemia and lymphocytic 
leukemia.  
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Figure 4. Strategy for High-throughput retroviral tagging and discovery of Sox4 as an oncogene in leukemia
Random integration of retroviruses induces stochastic activation of genes. B-cell tumours are screened for retroviral
integration sites (RISs) which are validated in myeloid tumours to unveil common integration sites (CISs).Asterisks
denote point mutations induced by retroviral random integration. Source: Suzuki, 2002.
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Sox4 in myeloid leukemia: a block in myeloid differentiation 
Expression of Sox4 is a requisite for normal haematopoiesis during embryonic 
development, but its aberrant expression leads to cellular transformation in the 
hematopoietic compartment. Indeed, forced expression of Sox4 in bone marrow explants 
is sufficient to induce malignization, either alone or in cooperation with a variety of pro-
oncogenic cues such as proviral insertion of Evi1 (Boyd et al., 2006), loss of Cdkn2b (Bies 
et al., 2010), upregulation of CREB (Sandoval et al., 2012), deregulation of Mef2C (Du et 
al., 2005), PU.1 haploinsufficiency (Aue et al., 2011), PML-RARα translocations (Omidvar 
et al., 2013), oncogenic C/EBPβ mutations (Zhang et al., 2013).  
Of note, many of such conditions are incapable of inducing myeloid 
leukemogenesis per se, in contrast to Sox4; however they notably accelerate the 
tumourigenesis onset and progression when combined with Sox4 overexpression. The 
mechanisms whereby Sox4 exerts such a central role in initiating and promoting 
leukemogenesis range from increased cell survival and proliferation, transcriptional 
repression of PU.1, increased self-renewal and potentiation of CREB-mediated 
transcription; all these facts result in a block in myeloid cell differentiation, thus coalescing 
around the major cause for myeloid leukemogenesis (Figure 5) (Vervoort et al., 2013b). In 
addition, the intriguing incidence of Sox4 overexpression in myeloid leukaemia patients 
bearing common chromosomal translocations such as AML1-ETO suggests a selective 
pressure to activate Sox4, most likely through epigenetic mechanisms, in support of a role 
for Sox4 as an oncogene that can potentiate the effect of pre-existing genetic lesions and 
act synergistically with them to drive the disease (Kvinlaug et al., 2011; Vervoort et al., 
2013b). 
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Figure 5. Schematic diagram summarizing the proposed mechanisms for Sox4-mediated oncogenesis in blood
malignancies.
Highlighted in blue are the mechanisms linked to myeloid leukemia and in red, mechanisms in lymphoid leukemia.
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Sox4 in lymphocytic leukemia: pro-survival & anti-apoptotic 
As above-mentioned, and in an analogous manner to myeloid leukemia, Sox4 is 
required for normal B-/T-cell development during embryogenesis. A prominent role for 
Sox4 has also been documented in blood malignancies other than myeloid leukemia. 
Among them, Sox4 has been shown to act as a critical activator of the PI3K/MAPK-
dependent signalling to promote survival of tumour cells, and Fra2-mediated expression of 
HDAC8 (which prevents apoptosis and increases cancer cell proliferation), thereby 
promoting T-/B-acute lymphocytic leukemia  (Higuchi et al., 2013; Ramezani-Rad et al., 
2013). The study of the Role of Sox4 during lymphomagenesis has revealed important 
hints into the molecular pathways that regulate Sox4 expression, such as TGFβ pathway 
and its regulation through micro-RNAs (miRNAs) (Wong et al., 2013; Zhao et al., 2011) 
(Figure 5). 
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V.2. Sox4 in solid malignancies 
 
In parallel to the compelling evidence of the prominent role that Sox4 exerts in 
blood malignancies, there has been an intense research activity gathered around the 
study of a possible function for this protein in solid tumourigenesis. Since the discovery 
that expression of Sox4 is sufficient to drive tumorigenesis, Sox4 overexpression has 
been found in virtually all major cancer types including lung cancer, bladder cancer, 
prostate cancer, hepatocellular carcinoma (HCC), glioblastoma, endometrial cancer and 
adenoid cystic carcinoma (ACC). Mirroring the number of molecular phenotypes arising 
from Sox4 overexpression in leukemia, there has been a number of findings associated to 
Sox4 upregulation in solid tumours as well (Table 2). Notably, there is a high dependence 
on tumour and cell-type specific contexts in the nature of such outcomes, which range 
from regulation of cell survival to activation of specific genes involved in cellular 
transformation (Jafarnejad et al., 2013a; Vervoort et al., 2013b).  
 
Sox4 regulates cell cycle and apoptosis 
Recapitulating the role of Sox4 in neural and mesenchymal progenitors during 
normal embryonic development and in acute-lymphoblastic leukemia, increased 
expression of Sox4 in prostate cancer and adenoid cystic carcinoma correlates with 
enhanced apoptosis resistance and greater cell survival, features that are reversed in ex-
vivo cell cultures treated with siRNA targeting Sox4, thus reinforcing the hypothesis that 
such mechanisms are intrinsically linked to Sox4 expression (Frierson et al., 2002; Liu et 
al, 2006; Pramoonjago et al., 2006; Veervort et al., 2013b). Indeed, Sox4 expression 
positively correlates with tumour grade in prostate carcinoma. In addition, forced 
expression of Sox4 in non-transformed cell lines ex-vivo is sufficient to confer colony-
forming abilities and support anchorage-independent growth in soft agar in vitro, indicating 
that Sox4 behaves as a potent oncogene also in solid tumours. The suggested 
mechanisms governing Sox4-mediated inhibition of apoptosis and enhanced survival 
include the control of cell cycle and proapoptotic regulators such as BCL10, PUMA, CSF1 
or CCNB1 as ascertained from microarray-based gene profiling of tumour cells depleted 
of Sox4 by siRNA (Frierson et al., 2002; Liu et al., 2006; Pramoonjago et al., 2006). 
Moreover, Sox4 has been shown to inversely correlate with p16, a main hub in cell cycle 
regulation and a molecular marker of ageing; in healthy lungs Sox4 decreases and p16 
increases with ageing, and in small cell lung carcinoma, wherein Sox4 becomes 
Introduction 
 
 29
reactivated to overcome cell cycle breaks (such as p16) and promotes a transcriptional 
program that boosts tumorigenesis (Castillo et al., 2012). 
 
 
The interaction among Sox4, p53 and DDR 
An interesting observation in some of these studies was the marked upregulation 
of p53 protein, by means of western-blotting, when Sox4 was targeted with siRNA. Such 
p53 accumulation was likely due to protein stability rather than transcriptional induction 
upon Sox4 interference, given the lack of evidence for significant p53 mRNA upregulation 
in any of the microarrays included in these studies (Liu et al., 2006; Pramoonjago et al., 
2006). Some studies focused thereafter in the putative interaction between Sox4 and p53, 
leading to an intense debate with paradoxical observations that still remain to be studied 
in depth and put into appropriate context to provide meaningful insights into Sox4 function 
in this regard. In particular, several reports postulated an interaction of Sox4 with the DNA 
damage response (DDR) pathway to modulate p53 levels. There is a substantial 
upregulation of Sox4 in HCT116 cells after treatment with DNA damage-inducing agents 
such as doxorubicin, UV irradiation or ionizing radiation (IR) but not with other cellular 
stressors such as hypoxia, heat shock or H2O2 treatment. Interestingly, this was shown to 
be a p53 independent but ATM/ATR-dependent phenomenon (Pan et al., 2009). Sox4 
interacts with p53 whereby it prevents Mdm2-mediated ubiquitination of p53 and its 
subsequent proteasomal degradation, resulting in increased p53 protein stability. 
However, in this context and in stark contrast with previous results, Sox4 downregulation 
resulted in a reduced stability of p53 protein, paradoxically pointing to a putative role for 
Sox4 as a tumour suppressor (Pan et al., 2009). A negative correlation between tumour 
prognosis and Sox4 expression (and thus in support of a tumour-suppressive effect of 
Sox4) was found in subsequent studies in a limited subset of human tumours including 
bladder cancer, HCC, gall bladder carcinoma and melanoma (Vervoort et al., 2013b). 
Nonetheless, the only type of tumour showing robust association of Sox4 with tumour-
suppressive functions along subsequent studies is melanoma (see below).   
An interesting observation is the fact that Sox4 confers resistance to DNA damage 
in medulloblastoma cell lines, thus alleviating the burden of the DDR upon irradiation. In 
this setting, Sox4 knock-down (KD) or inhibition through expression of SPARC (a bona-
fide endogenous peptide inhibitor of Sox4) renders cancer cells susceptible to IR. Even 
the mere reduction of Sox4 levels is sufficient to induce a mild DDR, as means of γH2AX 
accumulation (a marker for DNA lesions such as double-strand breaks or replication-
associated ssDNA) (Jackson and Bartek, 2009), and when challenged with sub-lethal IR 
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apoptotic rates were increased up to six fold. Importantly, these results were reproducible 
in vivo with transplanted tumours (Chetty et al., 2012). Overall, these studies suggest an 
intimate link of Sox4 with the DDR and p53-dependent apoptotic response in tumours, 
therefore open new therapeutic windows for certain tumours that could suffer from 
endogenous replication stress alleviated by Sox4, a feature that could be counterbalanced 
by means of Sox4 inhibition or downregulation to render cancer cells more susceptible to 
current treatments such as IR. 
 
Table 2. Status and role of Sox4 in different tissues. Adapted f rom Vervoort, 2013
Type of tumour Sox4 status and role
Splenic marginal zone lymphoma Common retroviral integration site (increased expression), positive correlation with disease progression
Myeloid leukemia Upregulated in myeloid leukemia, prevents myeloid differentiation, association with disease progression, associated to AML1-ETO translocation
Hpatocellular carcinoma Overexpressed, good correlation with metastasis
Medulloblastoma Increased expression compared to normal cerebellum, alleviation of DNA damage response and associated to radiation-resistance
Prostate cancer Increased expression compared to healthy tissue, associated with aggressiveness, EMT and metastasis
Lung cancer Gene amplification, prevents p16 activation upon oncogenic cues
Colorectal cancer Increased expression, associated to metastatic potential
Adenoid cystic carcinoma Increased expression relaqtive to normal tissue, prevents apoptosis and increases cellular viability
Bladder Cancer Increased expression and gene amplification
Glioblastoma multiforme Elevated expression compared to normal brain, favours cancer stem cell phenotype
Gallbladder carcinoma Elevated in primary tumours, reduced expression in advanced forms of the disease
Gastric cancer Elevated expression relative to normal tissue
Breast cancer Elevated in comparison to normal tissue, good correlation with tumour grade, promotes metastasis and EMT phenotype
Pancreatic cancer Upregulated when compared to normal tissue
Pheochromocytoma Upregulated when compared to normal tissue
 
 
 
Sox4 and metastasis: the control of EMT 
So far, it can be ascertained that Sox4 constitutes a key oncogenic event in the 
vast majority of tumours, that occurs in the initial stages of tumorigenesis. Nonetheless, a 
number of reports have demonstrated a prominent role for Sox4 also in regulating late 
cellular transformation steps. In particular, Sox4 expression levels strongly correlate with 
disease progression, metastasis and probability of relapse. In the breast cancer line MCF-
7, high Sox4 expression was associated to cancer stem cell-like properties in 
tridimensional collagen scaffolds concomitant with downregulation of epithelial markers 
such as ECDH, upregulation of cancer stem cell markers such as OCT4 and SOX2, and 
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higher tumorogeneicity in xenotransplants (Chen et al., 2012). Interestingly, independent 
studies demonstrated that higher Sox4 expression correlated with the triple-negative 
breast cancer subtype in humans (ER-/PR-/HER2-, associated with more aggressive and 
difficult to treat forms of breast cancer). In this study, ectopic Sox4 expression in the 
immortalized cell line MCF-10A was sufficient to induce a mesenchymal phenotype with 
increased migratory/invasive abilities. Sox4 itself is induced by TGFβ and required for the 
initiation of the EMT/metastatic programs (Vervoort et al., 2013a), and, in xenografts, 
Sox4 cooperates with oncogenic Ras mutations to promote tumorigenesis in vivo (Zhang 
et al., 2012). The induction of Sox4 by TGFβ is crucial for the induction of Ezh2 and 
subsequential epigenetic reprogramming of cancer cells to acquire a phenotype tailored 
for distant tissue colonization (Tiwari et al., 2013). The relevance of Sox4 in metastasis is 
evident in studies showing how breast cancer cell lines selected for their metastatic 
capacities in vivo display a selective pressure for losing endogenous miRNAs that 
regulate Sox4 expression among other targets (Tavazoie et al., 2008).  
 
 
The case of melanoma 
As aforementioned, the only human type of tumour displaying Sox4 
downregulation concomitant with disease progression is melanoma. This is the only 
setting in which in most cases Sox4 seems to behave as a tumour suppressor rather than 
as an oncogene (Jafarnejad et al., 2013a; Vervoort et al., 2013b). Tumour microarray 
analysis in various types of human melanocytic lesions shows that Sox4 is significantly 
reduced in advanced lesions when compared to primary melanoma or dysplastic nevi. 
Multivariate Cox analysis in human samples reveals controversial results, pointing out that 
Sox4 is an independent prognostic marker of disease progression (Jafarnejad et al., 
2010), either alone or in combination with a set of markers relevant for melanoma 
progression (Li et al., 2011) though sometimes despite finding similar trends, no 
significance was obtained for this marker alone (Zhang and Li, 2012); in human 
melanoma cell lines Sox4 plays a pivotal role in binding and inducing Dicer, thereby 
promoting a shift in the set of miRNAs expressed in dysplastic nevi vs invasive melanoma 
that controls cell proliferation and invasion (Jafarnejad et al., 2013b) or either inhibiting 
NF-κB subunit p50 transcription through yet unknown mechanisms (Jafarnejad et al., 
2010). Despite the mounting results showing correlation of Sox4 downregulation with 
melanoma progression, there is still a hot debate in this regard and no consensus on the 
prognostic significance of Sox4 as a biomarker in melanoma, given the lack of meaningful 
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insights into the molecular mechanism and consistency among studies (Jafarnejad et al., 
2013a). 
 
Altogether, the extensive research gathered around Sox proteins, and in particular 
the interest focused in Sox4, underlines the importance of these proteins in controlling 
numerous aspects of stem cell biology during important processes often associated to 
human disease. However, there is still a notable lack of appropriate research models that 
allow the complete understanding of the molecular properties of this intriguing factor in 
vivo and therefore facilitate the development and testing of new treatments useful to 
confront and new ideas to comprehend these age-associated pathologies. 
 
  
 
 
 
 
 
 
 
Objetivos
"(…) El hombre es el animal que pregunta. El día en que 
verdaderamente sepamos preguntar, habrá diálogo. Por ahora las 
preguntas nos alejan vertiginosamente de las respuestas.(…)" 
 
Julio Cortázar. Rayuela, Cap 147 
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El objetivo general de la presente Tesis Doctoral fue la generación de nuevas 
herramientas que permitieran el estudio in vivo de las funciones del factor de 
transcripción Sox4 en células madre y tejidos adultos. Los objetivos específicos fueron los 
siguientes: 
 
1. Generar un modelo de ratón con un alelo insertado en el locus genómico de Sox4 
(ratones Sox4lox/lox), cuya secuencia está flanqueada por sitios LoxP que permiten su 
escisión in vivo, para estudiar las células que expresan Sox4 y poder estudiar el efecto de 
la ausencia de expresión en dichas células. 
 
2. Determinar el impacto de la expresión reducida de Sox4 durante los procesos de 
adquisición de pluripotencia y durante la diferenciación de células madre. 
  
3. Estudiar la importancia de la expresión reducida de Sox4 en la homeostasis global y 
durante el envejecimiento.  
 
4. Comprobar la contribución específica de Sox4 a la arquitectura de la piel y a su 
mantenimiento en ratones con deleción condicional de Sox4 en piel. 
 
5. Caracterizar los efectos de la eliminación de Sox4 durante la regeneración del pelo y el 
cierre de heridas. 
  
6. Descubrir los cambios en los perfiles transcripcionales de la piel durante la 
regeneración del pelo en ausencia de Sox4. 
 
7. Estudiar la dependencia de Sox4 en la transformación de keratinocitos mediante 
tratamiento con carcinógenos. 
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Objectives 
"(…) 
 —Contáselo con todos los detalles —dijo Oliveira. 
—Oh, una idea general es bastante —dijo Gregorovius.  
—No hay ideas generales —dijo Oliveira..(…)" 
 
Julio Cortázar. Rayuela, Cap 15 
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The main goal of the present PhD thesis was to generate new tools to in vivo study 
the major functions of the Sox4 transcription factor in stem cells and adult tissues. In that 
context, we aimed to address the following specific objectives: 
 
 
1. To generate a reporter and excisable Sox4 KI mouse model for studying and 
tracking Sox4-expressing cells in vivo (Sox4lox/lox mice) 
 
2. To determine the impact of Sox4 downregulation in acquisition of pluripotency and 
stem cell differentiation. 
 
3. To study the importance of Sox4 downregulation in global homeostasis and ageing.  
 
4. To address the specific contribution of Sox4 to skin architecture and maintenance 
when conditionally deleted in skin 
 
5. To characterize the effects of Sox4 abrogation during hair regeneration and wound 
healing in Sox4cKO mice 
 
6. To unveil the changes in the transcriptional profile of skin undergoing hair 
regeneration in the absence of Sox4. 
 
7. To understand whether Sox4 is required for cellular transformation during 
chemically-induced skin carcinogenesis. 
 

  
 
 
 
 
 
 
 
Experimental Procedures
“(...) La rayuela se juega con una piedrita que hay que empujar con la punta del zapato. 
Ingredientes: una acera, una piedrita, un zapato, y un bello dibujo con tiza, 
preferentemente de colores. En lo alto está el Cielo, abajo está la Tierra, es muy difícil 
llegar con la piedrita al Cielo, casi siempre se calcula mal y la piedra sale del dibujo. 
Poco a poco, sin embargo, se va adquiriendo la habilidad necesaria para salvar las 
diferentes casillas (rayuela caracol, rayuela rectangular, rayuela de fantasía, poco 
usada) y un día se aprende a salir de la Tierra y remontar la piedrita hasta el Cielo, 
hasta entrar en el Cielo, (...), lo malo es que justamente a esa altura, cuando casi nadie 
ha aprendido a remontar la piedrita hasta el Cielo, se acaba de golpe la infancia y se 
cae en las novelas, en la angustia al divino cohete, en la especulación de otro Cielo al 
que también hay que aprender a llegar. (...)” 
 
Julio Cortázar. Rayuela, Cap. 36 
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I. ANIMAL EXPERIMENTATION 
 
In order to generate the Sox4+/KI mice, recombinant ES cells from a 129Sv 
background were injected into C57BL6 and the chimeras obtained were back-crossed 
with C57BL6 for a total of four generations and thereafter inter-crossed to expand the 
colony; therefore, all the mice used in this study were of mixed background 
C57BL6/129Sv (75%:25%). 
All animals were maintained at the Spanish National Cancer Research Centre 
(CNIO) under specific pathogen-free conditions, in agreement with the recommendations 
of the Federation of European Laboratory Animal Science Association (FELASA). Mice 
were fed a standard chow diet (Harland Tekland 2018, 18% of fat-based calorie content) 
and observed on a weekly basis by trained personnel. All the treatment protocols were 
evaluated and approved by the Ethical Committee of the Carlos III Health Institute, and 
the animals were supervised on a weekly basis by trained personnel. All the mice 
presenting any sign of morbidity (http://dels.nas.edu/global/ilar/Guide) were sacrificed in 
agreement with the guidelines for Humane End Point for Animals Used in Biomedical 
Research. 
 
 
I.1 Generation of a Sox4 Knock-In (Sox4KI) mouse model 
 
The targeting construct and the mice carrying the Sox4KI allele were generated by 
genOway (France; see Figure 6A for additional information) by means of standard 
procedures. In brief, the Sox4 locus was cloned from mouse ES genomic DNA 
encompassing the only Sox4 exon together with the 5’-UTR and 3’-UTRs and surrounding 
genomic regions. This allowed the generation of the homologous arms of the targeting 
construct and the targeting cassette containing the endogenous Sox4 unique exon 
sequence fused to an IRES-GFP-Luciferase cassette; a neomycin selection region 
flanked by FRT sites (specifically recognized by the Flpe recombinase) was also included 
for positive selection of recombinant ES cells, and the Sox4-IRES-GFP-NEOFRT  construct 
was flanked by LoxP sites (specific for Cre recombinase), allowing the excision of the 
whole cassette in a controlled time and tissue-specific manner to be performed. 
Mice bearing the NEOFRT sequence (Sox4+/loxFRT mice) were viable and fertile, and 
thus we proceeded further with the crosses with Flpe-expressing mice in order to 
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eliminate the neomycin cassette; we inter-crossed Sox4+/lox, once the NEOFRT region was 
deleted, in order to generate homozygous Sox4lox/lox mice.  
 
 
I.2 Genotyping strategy of Sox4 alleles by PCR 
 
30-50ng of total DNA were isolated from mouse tissues following standard 
procedures were subjected to PCR reaction using Platinum Taq (Invitrogen Cat. 10966) 
by following the manufacturer’s instructions (1.5mM MgCl2, 0.2mM/dNTP, 0.5µM/primer, 
0.05U Platinum Taq/reaction, 1µl DMSO and milliQ distilled water to reach a final volume 
of 20 µl  per reaction). The PCR program was as follows: 1min 94ºC + 35x(30sec 94ºC + 
30sec 60ºC + 3min 72ºC) + 7min 72ºC + keep at 8ºC. The genotyping PCR primers used 
were (See Figure 6B): 
 
Cre F: TTAATCCATATTGGCAGAACGAAAACG 
Cre R: CAGGCTAAGTGCCTTCTCTACA 
Genot-Sox4 F1: CCAGCATCTCTAACCTGGTCTTC 
Genot-Sox4 F2: TTGGAGCACGGAAAGACGAT 
Genot-Sox4 R: CAGGCCAGCTCTATGCACTTT 
Genot-Neo F: CACTTGTGTAGCGCCAAGTGC 
 
 
I.3 Body Imaging with DEXA 
 
Lean mass, fat content and bone mineral density were analyzed by Dual-Energy 
X-Ray Absorptiometry (DEXA) by using a Lunar PIXImus Densitometer (GE Medical 
Systems) on anesthetized mice with 2% isofluorane. Acquisition time was 5 min. Bone 
mineral density was calculated from a manually-restricted Region of Interest (ROI) 
including the whole left femur of the studied animals. 
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I.4 Plucking and wound healing in mouse skin 
 
For hair plucking protocol, mice were anesthetized in 2.5% Isofluorane / 1% 
Oxygen (kept during the whole procedure with gas masks adapted for mice) and were 
intraperitoneally administered Buprex solution as analgesic. 1cm2 of dorsal hair was then 
removed by manual plucking with tweezers and tape-stripping until only dorsal skin and 
no hair was visible in the plucked area. Hair regeneration was assessed by taking pictures 
from a fixed distance and hair-depleted regions were scored as a percentage of the initial 
plucked area with the help of ImageJ software. 
For wound healing assays, mice were anesthetized as above; 4-6cm2 of dorsal 
hair was removed with depilatory cream (Veet) and rinsed with distilled water. 24h later 
parallel-double wounds were performed under anaesthesia conditions in the upper region 
of the dorsal skin of the mice with 4mm biopsy punch device. Subsequent wounds were 
performed following a head-to-tail progression along the back skin of the mice every 3 
days and pictures were taken every second day and wound size assessed with a calliper. 
 
 
I.5 DMBA/TPA-mediated skin carcinogenesis 
 
For skin carcinogenesis assays 12-week-old mice (6-10 mice per genotype)  were 
hair clipped and a single dose (100µl) of a 100nM DMBA solution in acetone was 
administered topically in the lower part of the back skin in order to promote cancer-
initiating mutations. Thereafter, animals were treated every 3 days with 12µg TPA 
dissolved in 200µl acetone in order to induce a proliferative state in the skin that favours 
expansion of cells bearing oncogenic mutations. Mice were clipped once weekly right 
before TPA administration, and tumour burden was evaluated on a weekly basis, 
recording number and size of lesions (papilloma) as well as appearance of other skin 
conditions, such as melanocytic growths. Mice were sacrificed whenever signs of 
morbidity (caquexy, presence of tumours >15mm, etc) were detected and samples 
collected for assessment by an anatomic-pathologist. 
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I.6 Histology and IHC. Antibodies 
 
Mice were culled and tissues were collected and fixed immediately in 10% 
Formalin in PBS during 16h and embed into paraffin blocks. 5µm sections were mounted 
in poly-L-Lysine glass slides, deparaffinised and rehydrated. After that, either we 
performed Haematoxylin-Eosin staining or antigen retrieval in 10mM citrate buffer cooked 
under high pressure for 2min. Spurious peroxidise activity was removed by H2O2 and 
methanol treatment. After blocking, primary antibodies were incubated 16h at 4ºC, 
washed, further incubated with biotin-conjugated secondary antibodies and processed for 
standard indirect immune peroxidase detection (Vector Laboratories) using DAB as 
substrate (Dako). Finally, slides were slightly counter-stained with Haematoxylin-Eosin 
and analysed by light microscopy. For confocal microscopy, Alexa-fluor conjugated 
antibodies (Molecular Probes, Invitrogen) were used at 1:500 dilution, washed, 
counterstained with DAPI and mounted in Vectashield or ProLong Gold antifading 
reagents. Confocal microscopy acquisition and settings were as described for QFISH (see 
below). 
Antibodies used and dilutions were as follows: mouse monoclonal anti-GFP 
(Roche, 1:500), rabbit polyclonal anti-CK14 (Covance, 1:1000), rabbit polyclonal anti-
CK10 (Covance, 1:300), rabbit polyclonal anti-Loricrin (Covance, 1:500), rabbit polyclonal 
anti-p53 (CM5 Novocastra, 1:200), mouse monoclonal anti-Ki67 (Master Diagnostica, 
1:200), mouse monoclonal anti-Histone 3 phospho-Ser10 (Millipore, 1:200), mouse 
monoclonal anti-Histone 2 phospho-Ser139 (γH2AX, Millipore, 1:100), mouse monoclonal 
anti-p63 (Neo Markers, 1:100), rabbit polyclonal anti-TRF1 (homemade, 1:50) (Munoz et 
al., 2009).  
 
 
II. CELL CULTURE 
 
Unless otherwise specifically indicated, cells were cultured in DMEM (Dulbecco’s 
Modified Eagle’s Medium, Gibco) supplemented with 10% FBS (Foetal Bovine Serum, 
Sigma) and 1% antibiotic/antimycotic (Gibco). Culture plates were held in appropriate 
incubators at 37ºC, 16% O2 and 5% CO2. 
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II.1 Extraction and culture of MEFs and preparation of feeders 
 
Pregnant female mice were euthanized in a CO2 chamber 13.5dpc, and uterus was 
removed and kept on 1% Antibiotic/Antimycotic in PBS pre-warmed at 37ºC. Inside a 
tissue culture hood, each embryo was isolated and the extraembryonic layers were 
removed with a pair of forceps and tweezers. The embryo head was cut below the eye 
and preserved in an eppendorf tube placed on dry ice for genotyping. The rest of the 
embryo was transferred to a p35 dish containing 1ml of 2X Trypsin solution in PBS, 
chopped during 30sec with a razorblade and incubated at 37ºC. After 20min, the 
suspension containing the chopped embryo was aspirated up and down 15 times through 
a glass Pasteur pipette and incubated at 37ºC for 20 additional minutes. Then, the cell 
suspension was diluted in 15ml of 10% complete medium and transferred to a T75 bottle. 
When confluent, cells were resuspended in 1ml trypsin and split in a 1:3 ratio every 2-3 
days. For long-term preservation, 5x106 cells were frozen in 10% DMSO diluted in FBS. 
 
For generating Feeders, MEF were expanded up to passage 4-5 and when at 75-
90% confluence, incubated with 10µg/ml MitomycinC for 3h at 37ºC, washed twice in PBS 
and frozen at 5x106 cells per vial.  For co-culture with iPS or keratinocytes, 2,5x106 cells 
per p100, 4x105 cells per p35 or 1x104 cells per m96 well were seeded at least 2 days in 
advance in 10% complete medium on top of a porcine gelatine coating (10ml per p100 
dish of 1% porcine gelatin in milliQ distilled water were incubated during 10 min at RT, 
aspirated, air-dried and the Feeders were seeded in complete DMEM medium). Medium 
was changed as appropriate medium when co-cultured with iPS or keratinocytes. 
 
 
II.2 Transfection and Viral Transduction 
 
In order to produce retroviral particles containing the vectors encoding the genes 
of interest for subsequent transduction into mammalian cells, 4x106 293T packaging cells 
were seeded for 30 minutes in p100 dishes and transfected with 4µg of ecotropic 
packaging vector for mouse cells (pCL-Eco) and 4µg of the vector containing the gene of 
interest, using Fugene6 (Roche). One day after transfecting the 293T cells, the target 
MEF were seeded at a density of 2x105 cells per p35 dish or 8x105 cells per p100 plates, 
and fresh complete DMEM medium was added to the 293T cells. The following day, the 
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supernatant containing the viral particles was collected and replaced with fresh medium; 
the supernatant was filtered through a 0.45µm mesh and diluted 1/3 with complete 
medium. After addition of 8µg/ml of Polybrene, 2ml (p35) or 10ml (p100) of supernatant 
was added to the target MEF. This procedure was repeated every 8 hours for a total of 4 
rounds of infection. 
 
 
II.3 Generation and maintenance of ES and iPS cells 
 
MEF from the desired genotypes were retrovirally-transduced with pMX-Sox2, 
pMX-Oct3/4 and pMX-Klf4 at a ratio 1:1:1 as described. 24h after the last transduction 
round, complete medium was replaced by iPS medium (high-glucose DMEM 
supplemented with 1000U/ml LIF, 1% non-essential aminoacids, 15% KSR, 1% Glutamax 
and 0.1% β-mercapto-ethanol, Life Technologies) and subsequently fresh iPS medium 
was added daily. The cultures were kept until colonies became apparent (typically 10-15 
days) and then the dishes were either stained for Alkaline Phosphatase to asses 
reprogramming efficiency or picked for clonal expansion. Picked colonies were trypsinized 
and plated onto 96 well plates (1 clone per well), and upon establishment of iPS clones 
they were split every other day in a 1:5 ratio, and fresh KSR medium was added daily. ES 
were maintained in ES medium (high-glucose DMEM supplemented with 1000U/ml LIF, 
1% non-essential aminoacids, 15% dialysed FBS, 1% Glutamax and 0.1% β-mercapto-
ethanol, Life Technologies) For gelatine culture we used 2i medium (Complete iPS 
medium supplemented with 1µM MEK inhibitor and 3µM GSK3β inhibitor, Stemgent). The 
ES/iPS clones were preserved in a 2X freezing medium (20% DMSO, 40% KSR, 40% ES 
medium) after trypsinization, neutralization with ES medium and cell counting. Vials were 
preserved in liquid Nitrogen for long-term storage. 
 
 
II.4 Teratoma Formation and RA-mediated differentiation of stem cells 
 
For studying general iPS differentiation by teratoma-forming capabilities, 2x106 iPS 
cells were injected subcutaneously into nude athymic mice (FOXN1 mutant strain). 
Typically, the tumours started to form around 1 week post-inoculation, and size was 
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assessed on a weekly basis with a calliper on grafted tumours. When the grafts reached 
1.5cm length mice were sacrified and tumours collected for subsequent IHC analysis.  
RA treatment was used to assess neuro-ectodermal differentiation. 1x105 cells 
grown in gelatine and 2i medium were seeded into p35 gelatin-coated dishes. After 24h, 2i 
medium was switched to ES medium without LIF (Day 0), and the day after (Day 1) 
medium was changed to RA-containing ES medium (without LIF) at a concentration of 
1x10-6 M. Thereafter, fresh RA medium was added daily and cells collected as indicated 
for biochemical characterization. 
 
 
II.5 Extraction and culture of Peripheral Blood Mononuclear Cells (PBMCs) 
 
100µl of peripheral blood was obtained from the submandibular vein of restrained 
animals onto EDTA-containing tubes. Immediately after collection, the blood was 
resuspended in 10ml QIAGEN RBC buffer for erythrocyte lysis. After 15 min at 4ºC the 
cell suspension was vortexed and cells were pelleted at 450xg for 3min in conical 
polypropylene tubes; then, cells were either frozen in 10% DMSO-containing FBS or 
plated in 96-well Greiner plates in RPMI medium (RPMI supplemented with 10%FBS, 1% 
non-essential aminoacids, 1% sodium pyruvate, 1% HEPES, 0.1% β-mercapto-ethanol, 
1% antimycotic/antibiotic) for HT-QFISH analysis (see below). 
 
 
II.6 Extraction, culture and differentiation of Keratinocytes from adult mice 
 
For adult keratinocyte extraction, mice were clipped and then culled by cervical 
dislocation. After hair-spraying with 70% EtOH, skin was collected and kept in cold-ice 
PBS containing 1% antimycotic/ antibiotic. In a tissue culture hood, skins were stretched 
dermal side up in a p150 lid and subdermal adipose tissue was scraped with a scalpel. 
Once the fat was removed, skins were subjected to 15sec sequential washes in 10% 
Povidone Iodine in PBS, 70% EtOH and finally PBS with antibiotics,  skins were floated 
dermis side down in p100 dishes containing 10ml of EDTA-free trypsin and kept overnight 
at 4ºC. The day after, skins were stretched in sterile p100 lids, epidermal side up, and 
epidermis was scraped and minced with scalpels. After resuspending in EDTA-free trypsin 
with a 5ml pipet, cell suspension was filtered through a 70µm nylon mesh and neutralized 
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with 2ml of trypsin neutralizer. After addition of 10 ml of Keratinocyte Medium 02 
(CELLnTEC), cells were spun down at 500xg during 8min. Cell pellet was collected by 
aspirating 2ml from the bottom of the tube and resuspended in 10ml of Keratinocyte 
Medium 02 for cell counting. 
For keratinocyte differentiation, 5x103 keratinocytes were plated in triplicates in 2ml 
of Keratinocyte Medium 02 onto p35 dishes containing pre-seeded feeder layers and 
cultured at 37ºC in a 2% oxygen incubator. Fresh medium was added every 3-5 days, and 
when 10-50 cell colonies were visible, plates were fixed in 4% Formaldehyde for 30min at 
RT and stained with 1% Rhodamine B or 0.02% Giemsa in PBS during 30min at RT in an 
orbital shaker. Plates were rinsed with distilled water, dried o/n and colonies were scored 
on digital images with ImageJ after scanning the plates. 
 
 
II.7 Ras/E1a-mediated transformation of MEFs 
 
For assaying cell transformation, MEF were infected with a pBabe-RasG12V-IRES-
E1a construct following the standard retroviral infection protocol. After selection in 2µg/ml 
puromycin during 48h, cells were split in the presence of 1µg/ml puromycin and when 
cells reached confluence, 2x103 or 2x104 cells were seeded in p100 dishes and cultured 
for 10-15 days adding fresh medium once per week. When macroscopically visible 
colonies appeared (typically after 10-15 days) cells were fixed by adding 2ml of 37% 
Formaldehyde solution to the dishes containing 10ml of complete DMEM medium, and 
kept on an orbital shaker for at least 30min at RT. After removing the fixative, colonies 
were stained with a 0.02% Giemsa solution in PBS for 30 min at RT. The plates were 
washed in distilled water until the water run clear and dried overnight placed on top of a 
filter paper. Plates were scanned and colonies quantified with regard to their relative 
abundance and size distribution on digital images with ImageJ software. 
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III. IN VITRO ASSAYS AND CELL IMAGING 
 
III.8. Quantitative-Real Time PCR (qPCR) and Primers 
 
Total RNA isolation and DNA digestion was done with RNA later, RNEasy and 
DNAse I kits (QIAGEN) following manufacturer’s instructions. For cDNA synthesis, 0.5ng 
of total RNA were retro-transcribed with Advanced iScript and assayed using Power 
SYBR Green PCR Master Mix (Applied Biosystems). GAPDH and Actin were used as 
references and results were represented as relative to GAPDH levels. qPCR primers are 
listed below. 
 
Gene Forward Reverse
GAPDH 5’ GCA CAG TCA AGG CCG AGA AT 3’ 5’ GCC TTC TCC ATG GTG GTG AA 3’
Actin 5’ GGC ACC ACA CCT TCT ACA ATG 3’ 5’ GTG GTG GTG AAG CTG TAG CC 3’
Sox4 5’ GCC TCC ATC TTC GTA CAA CC 3’ 5’ AGT GAA GCG CGT CTA CCT GT 3’
Sox11 5’ ATC AAG CGG CCC ATG AAC 3’ 5’ TGC CCA GCC TCT TGG AGA T 3’
Sox12 5’ GAG CGG AGA AAA ATC ATG GA 3’ 5’ CGA GGC CGG TAC TTG TAG TC 3’
p16 5’ TAC CCC GAT TCA GGT GAT 3’ 5’ TTG AGC AGA AGA GCT GCT ACG T 3’
p19 5’ GCC GAC CGG AAT CCT 3’ 5’  TTG AGC AGA AGA GCT GCT ACG T 3’
GATA3 5’ TAC CAC CTA TCC GCC CTA TG 3’ 5’ AGG ATG TCC CTG CTC TCC TT 3’
Tcf3 5’ GGA GCC GGG GCA ACC AGT G3’ 5’ CAT CCT GGG GCC TTC TCA CTT C 3’
Tcf4 5’ CAC CCG GCC ATC GTC ACA C 3’ 5’ GCC ACC TGC GCC CGA GAA T 3’
Sox9 5’ GAC TCC CCA CAT TCC TCC TC 3’ 5’ CCC TCT CGC TTC AGA TCA AC 3’
c-Myc 5’ AAG CCA CCG CCT ACA TCC TG 3’ 5’ AAA GCC CCA GCC AAG GTT G 3’
mTERT 5' GGA TTG CCA CTG GCT CCG 3' 5' TGCCTGACCTCCTCTTGTGAC 3'
Nanog 5' CAGGTGTTTGAGGGTAGCTC 3' 5' CGGTTCATCATGGTACAGTC 3'
Oct4 5' TCTTTCCACCAGGCCCCCGGCTC 3' 5' TGCGGGCGGACATGGGGAGATCC 3'
Rex1 5' ACG AGT GGC AGT TTC TTC TTG GGA 3' 5' TAT GAC TCA CTT CCA CGG GGC ACT 3'
 
 
III.1 Transcriptional profiling by microarray hybridization 
 
Total RNA was extracted from pluck skin of the indicated genotypes after 
immediate preservation in RNA later with the QIAGEN RNEasy Mini Kit, following 
manufacturer’s instructions. RNA Integrity Number (RIN) was in the range 7 to 9.8 when 
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assayed by Lab-chip technology on an Agilent 2100 Bioanalyzer. 100ng of total RNA were 
labelled with commercial "One-Color Microarray-Based Gene Expression Analysis (Low 
Input Quick Amp Labeling)" version 6.5 kit by following manufacturer instructions, and 
purified with silica-based spin columns (BioRad). 
For Microarray hybridization, a Mouse Gene Expression 60K (Agilent) was used in 
a SureHyb hybridization chamber (Agilent) during 17h at 65ºC. The microarrays were 
scanned in a G2505C DNA microarray scanner (Agilent). Images were analysed by 
Agilent Feature Extraction Software (ver. 10.7) without background substraction. The 
resulting TIF images were transformed into low resolution false-colour JPEG images. The 
raw data files were used to generate .txt files for further quantification and annotation with 
the FeatureExtraction software. Genes were ranked according to their FDR, P values and 
fold enrichment, and only those showing a FDR<0.15 were considered Differentially 
Expressed Genes (DEGs). 
 
 
III.2 Gene set enrichment analysis	
 
Gene Set Enrichment Analysis was performed using annotations from the KEGG, 
Reactome and NCI databases, or by testing in-house made gene lists extracted from the 
TransFac repository or signatures found in published research articles (indicated when 
appropriate). Genes were ranked using the t statistic. After Kolmorogov-Smirnoff 
correction for multiple testing, only those pathways bearing a FDR<0.15 were considered 
significant. The Gene Ontology GO terms (biological proccesses, cellular components and 
molecular functions), Genecard and Malacard annotations were included and annotated 
according to published literature. Enrichment plots were also obtained with GSEA, and 
ranked according to their enrichment score (ES). 
 
 
III.3 Telomere Quantitative Fluorescence In-Situ Hybridization (QFISH) 
 
In order to perform QFISH in metaphase nuclei of mouse tissues, paraffin-embed 
organs were processed as described (Methods, section I.6). Then, 5µm sections were 
attached to Poly-L-Lysine-covered glass slides. After deparaffinization and antigen 
retrieval, tissues were fixed in 4% Formaldehyde, washed 3x5min in PBS and incubated 
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in pepsin solution (0.1% Porcine Pepsin (Sigma) containing 0.01M HCl (Merck)) 10min at 
37ºC. After another round of washes and fixation as above-mentioned, slides were 
dehydrated in a 70% - 90% - 100% Ethanol series (5min each). After 30 min of air drying 
50µl of Telomere probe mix (10mM TrisCl pH7, 25mM MgCl2, 9mM Citric Acid, 82mM 
Na2HPO4 (adjusted to pH7), 70% Deionised Formamide (Sigma), 0.25% Blocking 
Reagent (Roche) and 0.5µg/ml Telomeric PNA probe (Panagene)) were added to each 
slide. After putting a cover slide on top of it, DNA was denatured by heating during 3min at 
85ºC, and further incubated for 2h at RT in a wet chamber in the dark. Finally, slides were 
washed 2x15min in Washing Solution I (10mM TrisCl pH7, 0.1% BSA in 70% 
Formamide), then 3x5min in Washing Solution II (TBS 0.08% Tween-20) and then 
incubated with 4µg/ml DAPI (Sigma) and mounted in Vectashield mounting medium 
(VectorTM). For analysis, confocal image stacks were acquired every 0.5µm for a total of 
10µm by using a  Leica SP5-MP confocal microscope and maximum projections were 
generated and analysed using LAS-AF software and TFL-Telo (A kind gift of Peter 
Landsorp)  
 
 
III.4 High-Throughput QFISH (HT-QFISH) 
 
PBMCs were obtained as described above. 96-well Greiner plates were pre-coated 
with 1:10 Poly-L-Lysine in milliQ distilled water for 30min at 37ºC, at a density of 1,2x105 
cells per well. The cells were incubated during 2h at 37ºC and then fixed 3x5min in 200µl 
with a multichannel pipette in Methanol:Acetic Acid 3:1. Fixed cells were preserved at -
20ºC until use. Then, plates were dehydrated o/n in an air-jacketed 37ºC incubator, then 
rehydrated 5min in PBS and fixed again in 4%PFA in PBS. After 3x5min PBS washes, the 
plates were included in a Styrofoam frame floater and digested in Pepsin 15min in a 37ºC 
water bath. After digestion, samples were fixed and washed as above mentioned. Then, 
the plates were dehydrated in EtOH (5minx70% EtOH, 5minx90% EtOH and 5minx100% 
EtOH) and dried for 30min in a 37ºC incubator. After dehydration, 50µl of Cy3-Telomeric 
probe mix were added to each well and denatured 5min at 85ºC in a hot plate. The 
Greiner plates were hybridized then for 2h at RT in the dark and washed 2x15min in 
washing solution I, then 3x5min in washing solution II, then 1x5min in PBS with DAPI and 
then mounted using Mowiol solution (Calbiochem). 
Images were acquired using an automated Opera Confocal High-throughput 
microscope (PerkinElmer), and analysed with Acapella software to obtain mean telomere 
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intensity. Briefly, DAPI signal was used to create nuclei masks in which telomeric spots 
were identified and classified depending on their intensity. 60 images per well were 
captured from duplicate wells, and at least 5x103 telomeres were analysed per sample. 
For normalization and transformation of a.u.f. into Kilobases, LY-R and LY-S reference 
lymphoma cell lines with known telomere length (70.9Kb and 11.2Kb, respectively) were 
included in each plate. 



  
 
 
 
 
 
 
 
Results 
"(…) Pero detrás de toda acción había una protesta, porque todo hacer significaba salir 
de para llegar a, o mover algo para que estuviera aquí y no allí, o entrar en esa casa en 
vez de no entrar o entrar en la de al lado, es decir que en todo acto había la admisión de 
una carencia, de algo no hecho todavía y que era posible hacer, la protesta tácita frente 
a la continua evidencia de la falta, de la merma, de la parvedad del presente. Creer que 
la acción podía colmar, o que la suma de las acciones podía realmente equivaler a una 
vida digna de este nombre, era una ilusión de moralista. (…)” 
 
Julio Cortázar. Rayuela, Cap 3 
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I. Generation of mice with an excisable Knock-In allele for Sox4 
 
The fact that complete Sox4 abrogation (Sox4-/- mice) results in embryonic lethality 
(Schilham et al., 1996) has hampered understanding the role of Sox4 in the adult 
organism. To circumvent this, we decided to generate a Sox4 Knock-In (KI) mouse model 
(Sox4lox/lox mice), which would allow us to conditionally delete Sox4 as well as to in vivo 
track Sox4-expressing cells in adult tissues. To do so, we generated a KI construct 
targeted to the Sox4 locus including the whole Sox4 5’- and 3’-UTR and the full length 
Sox4 unique exon adjacent to an Internal Ribosome Entry Site-Green Fluorescent 
Protein-Luciferase (IRES-GFP-Luc) reporter coding sequence. We flanked the KI allele 
with LoxP sites in order to allow the excision of the whole cassette with tissue-specific Cre 
recombinase. We included FRT sequences in order to remove the neomycin cassette by 
crossing the founders with Flp-expressing mice. When intact, the KI cassette is regulated 
by the endogenous Sox4 promoter and its transcription is expected to give rise to the full-
length Sox4 protein simultaneously to a GFP-Luc protein (Figure 6A and B). 
 
A B
F2
-R 530 bp
3330 bp
F1
-R
250 bp
Sox4lox
Sox4+
Sox4lox
Sox4+
F1 R
250 bp
3’-UTR5’-UTR E1 Chr.13
Sox4lox 5’-UTR E1 GFP-LucIRES
LoxP F1 R
3’-UTR
LoxP
3300 bp
F2
530 bp
FRT
Figure 6. Generation of Sox4-IRES-Luc-GFP Knock-In mouse model
(A) Schematic of the different Sox4 alleles. The Forward-WT (F1), Forward-KI (F2) and Reverse (R) genotyping
primers (red arrows) and PCR sizes in base pairs (bp) are depicted. See Supplementary Table 4 for detailed primer
sequences.
(B) Genotyping PCR of the dif ferent Sox4 alleles.
 
 
II. Sox4 is dispensable for pluripotent cell generation and differentiation 
 
In 2006, Takahashi and Yamanaka demonstrated that it is possible to reprogram 
the cell’s differentiated status to ES-cell like status, giving rise to the so-called induced-
Pluripotent Stem cells (iPS cells) by inducing the expression of only four factors, namely 
Klf4, Oct4, c-Myc and Sox2 a method that soon was proven equally efficient disposing of 
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c-Myc, allowing the generation of iPS with only three factors (3F) (Marion et al., 2009; 
Takahashi et al., 2006). Ever since, nuclear reprogramming has become a powerful tool to 
address the influence of a given condition in the acquisition and maintenance of 
pluripotency. 
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Figure 7. Sox4 is dispensable for the generation of iPS but required for efficient reprogramming
(A) Schematic of reprogramming into iPSC or dif ferentiation of mESC protocols.
(B and C) Dynamics (Days) of Sox4 (green, right Y axis) and Nanog (purple, lef t Y axis) along reprogramming (lef t
panel) or dif ferentiation (right panel). Data is relative to GAPDHx10-3, n=3 experiments.
(D) Alkaline phosphatase staining of reprogramming plates.
(E) Genotyping PCR to conf irm AdCre-mediated excision of Sox4 locus in iPS clones. Yellow asterisks, not excised KI
cassette escaper clones; red, excised cassette.
(F) Relative reprogramming eff iciency, relative Sox4 mRNA levels and total mRNA expression levels (relative to
GAPDHx10-3) of Nanog, Oct4 and Rex1, respectively, in iPSC clones of the indicated genotypes.
Depicted is mean and SEM Only signif icant P values are shown (two-tailed Student’s t test , P<0.01)
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Given that most of the principal roles of Sox4 are related to stem cell maintenance 
and differentiation, we wanted to address a possible role for Sox4 in the biology of 
pluripotent stem cells. To that end, we performed reprogramming assays in WT MEFs 
using the Yamanaka cocktail of three factors (3F) and differentiation assays in mESC with 
retinoic acid (RA; Figure 7A) and measured Sox4 mRNA. We observed a decrease of 
Sox4 expression during reprogramming and a sharp increase during differentiation 
protocols, as opposed to Nanog (Figure 7B and C), suggesting that Sox4 is induced 
during the differentiation of mESC and repressed during acquisition of pluripotency. To 
study the function of Sox4 during reprogramming, we infected Sox4lox/lox and Sox4+/+ MEF 
with adenoviral vectors expressing Cre recombinase (AdCre) prior to reprogramming. We 
observed a ≈50% decrease in reprogramming efficiency; however, the iPS clones with 
proven excised Sox4 cassette expressed largely normal expression levels of pluripotency-
associated factors such as Nanog, Oct4 and Rex1(Figure 7D-F). To understand whether 
these Sox4-deficient iPS clones could have defects during differentiation into specific 
lineages, we performed teratoma-mediated differentiation by subcutaneous injection into 
nude athymic mice. We detected slower growth rates in Sox4-depleted iPS undergoing 
differentiation, without reaching significance (Figure 8A). Nevertheless, we obtained 
tissues from the three embryonic layers, as assessed by IHC (Figure 8B). These results 
are indicative that Sox4 is largely dispensable for reprogramming and differentiation. 
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Figure 8. Sox4-deficient iPS are pluripotent
(A) Dynamics of teratoma growth (n=5 clones per genotype).
(B) IHC of the three embryonic layers, obtained from teratomas of the indicated genotypes. AFP, alpha-feto protein
(endoderm); CKAE1/AE3, cytokeratins AE1 and AE3 (ectoderm); α-SMA, a-smooth muscle actin (mesoderm). Insets
depict magnif ication.
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III. Sox4lox/lox mice show signs of premature ageing and are cancer-resistant 
 
Sox4lox/lox mice are viable and fertile, but they are born under sub-mendelian ratios 
(Figure 9A). Moreover, Sox4lox/lox mice show a reduced body size and weight compared 
with their Sox4+/+ littermates (Figure 9B and C). These differences were increased when 
mice grew older (Figure 9C). Dual-Energy X-Ray Absorptiometry (DEXA) indicated that 
reduced weight could be attributed to a decrease in both lean and fat mass (Figure 9D).  
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Figure 9. Characterization of Sox4-IRES-Luc-GFP Knock-In mouse model
(A) Mendelian ratios, in two dif ferent cross settings, of Sox4lox/lox, Sox4+/lox and Sox4+/+ pups. P values were calculated 
using Fisher’s exact test.
(B) Macroscopic aspect of  Sox4+/+ and Sox4lox/lox mice. Genotypes are included. Note the marked size reduction and 
increased pigmentation in exposed skin (red arrowheads). 
(C) Plot of  the average weight in grams (g) of  a group of  male mice of  the indicated genotypes.
(D) (Lef t) DEXA images of  adult male Sox4+/+ and Sox4lox/lox mice. (Right) Fat mass (%) and grams of  lean mass 
Sox4+/+ and Sox4lox/lox mice. 
 
In addition, Sox4lox/lox mice have a significantly reduced longevity when compared 
to Sox4+/+ or Sox4+/lox mice (Figure 10A-D). This decreased survival paralleled an early 
onset of various age-associated pathologies. In particular, Sox4lox/lox mice present brittle 
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bones due to decreased bone mineral density (Figure 10E), and a higher incidence of 
intestinal failure, chronic hepatic failure, skin hyperpigmentation and dilated 
cardiomyopathy (Figure 10F and Table3). We also found an increased incidence of 
congenital diaphragmatic hernia and pyometra (Figure 10F and Table3). Furthermore, the 
humane end point was significantly anticipated in Sox4lox/lox compared to control mice 
(Figure 10A-D and Table3).  
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Figure 10. Accelerated ageing in Sox4lox/lox mice.
(A) Kaplan-Meyer survival curves of the indicated
cohorts (mixed sexes).
(B) Plot of the lifespan of the 10-longest-lived mice of
the indicated genotypes.
(C and D) Kaplan-Meyer survival curves of the
indicated cohorts. Sexes are separated as male (C)
and female (D)
(E) Bone mineral density obtained with DEXA.
(F) General aspect upon humane-end point necropsy
of Sox4lox/lox mice. Yellow, dilated cardiomyopathy;
green, congenital diaphragmatic hernia; blue,
pyometra.
P values refer to comparison with Sox4+/+ mice (Log-
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These signs of accelerated ageing and decreased longevity are coincidental with a 
notable reduction in the mean telomere length of peripheral blood cells, a bona fide 
indicator of biological aging (Canela et al., 2007; de Jesus and Blasco, 2012; Lopez-Otin 
et al., 2013; Vera et al., 2012) (Figure 11A). Interestingly, these mice also display 
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resistance to spontaneous cancer incidence when compared with Sox4+/+ mice (Figure 
11B).  
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Figure 11. Reduced telomere length and cancer incidence in Sox4 hypomorphic mice
(A) HTQFISH in mice of  the indicated age and genotype. Indicated is the number of  mice per group of  age and 
genotype. P=Student’s t test, n=number of  mice per age group and genotype.
(B) Spontaneous cancer incidence in the indicated genotypes, classif ied according to the type of cancer; bars represent 
the percentage of  af fected mice. Fisher’s exact test was used for comparison.
 
Together, these findings indicate that Sox4lox/lox mice show signs of premature loss 
of tissue homeostasis and a subsequent accelerated onset of age-associated pathologies. 
In addition, Sox4lox/lox mice also show a significant cancer resistance. 
 
 
IV. Sox4lox/lox mice are hypomorphic  
 
The above results point out to hypomorphic behaviour of the Sox4 KI allele. In 
order to demonstrate this, we performed indirect inmunohistochemistry (IHC) for GFP in 
tail skin sections given that Sox4 mRNA has been detected in skin (Dy et al., 2008; Greco 
et al., 2009; Lowry et al., 2005). We failed to detect any positive GFP signal in any skin 
region, indicating either very low expression levels of KI cassette or absence of Sox4 
expression in adult mouse skin (Figure 12A). To confirm this, we performed Sox4 
quantitative-Real Time RT-PCR (qPCR) in a panel of tissues from both Sox4lox/lox and 
Sox4+/+ mice. We found an approximated 10-fold reduction in the Sox4 mRNA levels in all 
the analyzed tissues, therefore demonstrating reduced Sox4 expression in Sox4lox/lox mice. 
Notably, we did not detect a significant deregulation of the other SoxC class members 
(Sox11 and Sox12) in the analyzed tissues (Figure 12B). Altogether, these findings 
demonstrate that our Sox4lox/lox mouse model behaves as a functional hypomorph for 
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Sox4 mRNA expression levels, and thus constitutes the first viable adult mouse model 
with whole-body reduced Sox4 expression. 
 
 
Sox4lox/llox
n=22
Sox4+/l+
n=12Parameter Category
Fisher’s
exact test
Sex 6 (50.0%)
Male 
(%)
14
(63.6%) p=0.34
Diaphragmatic hernia
0
(0%)
Affected
(%)
16
(72.7%) p<0.001
Dilated Cardiomyopathy
and heart hypertrophy
8
(36.4%)
1 
(8.3%)
Affected
(%) p=0.083
Pyometra 4(50.0%)
0
(0%)
Affected
(% of  Female) p=0.03
Intestinal failure (oedema, amiloidosis, 
hyperthropic caecum,  etc)
7
(31.8%)
1
(8.33%)
Affected
(%) p=0.13
Renal failure (chronic glomerulonephritis, 
amiloidosis, calculus, etc
4
(33.3%)
Affected
(%)
5
(22.7%) p=0.58
Hepatic failure (necrosis, chronic hepatitis, 
amiloidosis, congestion, steatosis, etc)
12
(54.5%)
2
(16.7%)
Affected
(%) p=0.035
Skin atrophy 8(36.4%)
5
(41.7%)
Affected
(%) p=0.52
Skin hyperpigmentation 5(22.7%)
0
(0%)
Affected
(%) p=0.09
Age at H. E. P. (Weeks) Mean (Range)
53.8
(17-81)
106.9
(72-139) p<0.001
Table 3. Main histopathological f indings in Sox4 hypomorphic (Sox4lox/lox) mice compared to their wild type counterparts 
(Sox4+/+) at humane end point. 	
	
V. Generation of a Sox4 conditional KO mouse model in stratified epithelia 
 
The above results indicate that adult mice with reduced Sox4 levels show a faster 
loss of normal tissue homeostasis. As the latter relies on a controlled balance between 
tissue replenishment and degeneration, we hypothesized that organ failure could be due 
to defects in the activity of adult stem cells. In order to test this, we abrogated Sox4 in skin 
as a model for adult stem cell function.  Sox4 is hitherto the only SoxC class member 
whose expression has been detected in developing and adult skin (Dy et al., 2008; Lien et 
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al., 2014; Lowry et al., 2005). To this end, we crossed Sox4lox/lox mice with K5Cre 
transgenic mice (Ramirez et al., 2004), giving rise to Sox4+/+; K5CreTg/+ (Sox4WT) and 
Sox4lox/lox; K5CreTg/+ (Sox4cKO) mice. As expected, Sox4cKO mice lack Sox4 mRNA 
expression in tail skin epidermis when compared to Sox4WT and show no differences in 
the expression levels of Sox11 and Sox12 (Figure 13A and B).  
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Figure 12. Expression of SoxC factors in Sox4 hypomorphic mice
(A) GFP IHC in tail skin sections f rom Sox4+/+ and Sox4lox/lox mice.
(B) Sox4, Sox11 and Sox12 qPCR in the indicated tissues f rom Sox4+/+ and Sox4lox/lox mice. P values are obtained with 
Student’s t test, n=number of  mice per genotype.  
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Finally, we did not find any significant change in the lifespan of mice with or without 
the K5Cre transgene (Figure 14), therefore unless specifically mentioned we refer 
hereafter to Sox4+/+; K5CreTg/+ and Sox4+/+; K5Cre+/+ mice collectively as Sox4WT mice. 
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Figure 14. Expression of Cre
recombinase in stratified epithelium
does not affect global homeostasis.
(A-C) Kaplan-Meyer survival curves of
the indicated cohorts and genotypes.
Long-rank test was used for comparison.
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VI. Sox4 is dispensable for normal skin development 
 
In order to assess a role for Sox4 during skin development, we studied skin 
differentiation markers in Sox4cKO and Sox4WT mice. We did not find differences in the 
assembly or disposition of Cytokeratin 10 (CK10, committed basal keratinocytes), 
Cytokeratin 14 (CK14, epidermal keratinocytes) or Loricrin (terminally-differentiated, 
cornified layer of keratinocytes) (Fuchs, 1994) (Figure 15A). In addition, Sox4cKO mice 
displayed a normal hair coat in a gross examination (Figure 15B), indicating that Sox4 is 
largely dispensable for normal skin specification and stratification. Being hypomorphic in 
all other tissues Sox4cKO mice also display reduced weight and lifespan, (Figure 15C and 
Figure 14A-C). 
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Figure 15. Sox4 is dispensable for skin stratification
(A) IHC of tail skin sections from mice of the indicated genotypes.
(B) General aspect of Sox4cKO and Sox4WT mice. Orange arrowhead, hyperpigmentation (magnified)
(C) Weight plots of male Sox4cKO and Sox4WT mice.
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VII. Sox4 deficiency results in premature skin ageing 
 
Decreased Sox4 expression resulted in skin hyperpigmentation and a thinning of 
the IFE (Figure 15B and Figure 16). These phenotypes are also observed in mice with 
increased DNA damage in the skin owing to telomere dysfunction (Martinez et al., 2009; 
Munoz et al., 2005; Tejera et al., 2010).  
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Figure 16. Reduced epidermal
thickness in the absence of
Sox4
(Lef t) Haematoxylin and Eosin 
labeling (H&E) in tail skin section 
of  adult Sox4WT and Sox4cKO
mice. (Right) Quantif ication of  the 
epidermal thickness shown in lef t 
panel. N=number of  mice per 
genotype, p values arise f rom 
Student’s t test.  
 
We also detected decreased proliferation rates at the IFE and Infundibulum but not 
at low proliferative compartments such as the bulge (Bg) and the sebaceous glands (SG) 
(Figure 17). This points out to a possible defect in the response to proliferative stimuli in 
the absence of Sox4 in proliferative skin compartments, which in turn may lead to 
premature skin aging phenotypes. 
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Figure 17. Reduced proliferation in Sox4cKO mouse tail skin
Ki67 staining in tail skin sections of  mice f rom the indicated genotypes (lef t) and quantif ication of  the percentage of  
proliferative cell per compartment (right). N=number of  mice per genotype, Student’s t test.  
 
To address whether Sox4 deletion leads to accelerated skin degeneration, we 
studied several molecular biomarkers of ageing. First, we performed Quantitative telomere 
Fluorescent In-Situ Hybridization (QFISH), which allows determination of telomere length 
at a single cell level (Flores et al., 2008) in tail skin sections from 6-month old mice. We 
detected a marked decrease in the mean telomere length in the differentiated skin 
compartments, such as the IFE in Sox4cKO mice (Figure 18A and B), indicative of 
replicative ageing. This was paralleled by significant accumulation of short telomeres and 
reduced abundance of long telomeres in the IFE (Flores et al., 2008) (Figure 18B). 
Strikingly, we observed a tendency to accumulate long telomeres in the hair bulge of 
Sox4cKO mice (Figure 18C and D), suggestive of decreased replicative history of Sox4-
depleted HFSC and possible defects in exiting quiescence (see below).  
Dysfunctional or critically short telomeres have been shown to behave as DSBs 
by inducing a DNA damage response at chromosome ends, forming the so-called 
Telomere-Induced foci (TIFs) (de Lange, 2009). In order to assess whether the increased 
abundance of short telomeres could be a source of damage to Sox4-depleted IFE 
keratinocytes, we performed co-staining of γH2AX and Telomere End Repeat binding 
Factor 1 (TERF1, hereafter referred to as TRF1) to visualize DNA damage at telomeres in 
tail skin sections. We detected increased amounts of γH2AX in Sox4cKO mouse IFE 
(Figure 19A and B). While we observed a preferential distribution of γH2AX foci in non-
telomeric regions in Sox4WT keratinocytes, in agreement with normal telomere length, 
Sox4cKO mouse skin showed a shift towards increased presence of γH2AX foci at 
telomeres or TIFs, thus suggesting increased DNA damage arising from telomeres in the 
absence of Sox4 (Figure 19C). 
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Figure 18. Accumulation of molecular markers of ageing in Sox4-depleted mouse skin (I)
(A) QFISH on adult mouse (6 month-old) tail skin IFE. Dermis and Epidermis are indicated, depicted is also 
magnif ication (Magn.).
(B) Mean telomere length (lef t), percentage of  short telomeres (middle) and long telomeres (right) at the IFE. 
(C) QFISH on adult mouse tail skin (Bulge region). 
(D) Mean telomere length (lef t), percentage of  short telomeres (middle) and long telomeres (right) f rom the bulge 
region. 
N=number of  mice per genotype, Student’s t test was done for comparison.  
 
Given that skin hyperpigmentation is also linked to DNA-damage-dependent p53 
upregulation (Cui et al., 2007), we next determined p53 expression in Sox4-depleted skin, 
which is also a marker of replicative senescence and DNA damage in vivo (Collado et al., 
2007). We observed a moderate but significant increase in the amount of p53-positive 
cells by IHC at the IFE compartment of the skin (Figure 19D). This was paralleled by a 
significant increase in the age/senescence markers p16 and p19 as detected by qPCR in 
isolated epidermal sheets of 6 month-old mice (Figure 19E).  
Altogether, our results showing shortened telomeres, accumulation of DNA 
damage, and increase senescence markers as a consequence of Sox4 deletion confirm a 
contribution of Sox4 to skin maintenance and a pro-ageing phenotype in Sox4-depleted 
tissues. 
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Figure 19. Accumulation of molecular markers of ageing in Sox4-depleted mouse skin (II)
(A) TRF1 and γH2AX staining in tail skin IFE f rom Sox4WT and Sox4cKO mice. TIFs are indicated with empty 
arrowheads, non-telomeric γH2AX foci are indicated by white arrowheads.
(B) Proportion of  cells with the indicated γH2AX foci at the IFE f rom mice of  the indicated genotypes. 
(C) Distribution of  H2AX staining between telomeric (TIFs) and non-telomeric foci.
(D) (Lef t) p53 IHC in 6 month-old mouse tail skin. (Right) p53-positive cells at the IFE (%). 
(E) p16 (lef t) and p19 (right) qPCR analysis of  tail skin epidermal extracts f rom adult Sox4WT and Sox4cKO mice. 
N=number of  mice per genotype, Student’s t test was done for comparison.  
 
 
VIII. Sox4 is induced upon plucking and modulates hair regeneration and wound 
healing 
 
It is possible to force unscheduled entry into the hair cycle by physically removing 
a portion of the hair coat. Following plucking, resting HFSCs exit quiescence, become 
activated and proliferate while differentiating into all the hair lineages (Keyes et al., 2013; 
Muller-Rover et al., 2001) (Figure 20A). To test whether Sox4 expression is induced 
during the plucking-induced anagen response, we depilated a group of Sox4WT mice and 
determined mRNA expression levels for several markers of HFSC activity. We found 
upregulation of GATA3, Tcf3/4, mTERT, Sox9 and c-Myc in a step-wise manner, 
confirming sequential activation of HFSCs after plucking (Greco et al., 2009) (Figure 20B).  
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Figure 20. Sox4 is induced in the anagen phase upon plucking response
(A) Schematic of  the timing of  HFSC activation dynamics upon plucking. Symbols are: green, resting bulge HFSC; blue, 
dif ferentiated cells; yellow, activated HFSC; and red, hair progeny. The timeline (in Days, D) is indicated on top of  the 
graph. 
(B) qPCR analysis of  genes relevant for epidermal activation along hair regeneration (mid and late anagen, D6 and 
D12, respectively). 2-3 mice per condition were analyzed. Student’s t test was used for comparison.  
 
Sox4 was similarly induced during hair regeneration (Figure 21A). None of the 
other SoxC class members showed significant changes after plucking, indicating 
functional specificity of Sox4 in the context of epidermal stem cell activation (Figure 21A). 
To test whether Sox4 increased expression was required for hair regeneration we plucked 
Sox4WT and Sox4cKO mice. We observed complete fur regeneration in Sox4WT mice 12-15 
days after plucking, while Sox4cKO mice displayed a delayed hair growth although 
eventually they also resumed full hair coat regeneration (Figure 4D). 
Hair regeneration relies on the activity of HFSCs, located in the hair bulge in mice 
(Fuchs, 2009). Other HFSC populations can also contribute to tissue replenishment in 
other regions than the hair progeny. Among them, the Junctional Zone (JZ)/Lrig1-positive 
cells can also contribute to the IFE regeneration (Jensen et al., 2009). To understand 
whether Sox4 could be required also for proper IFE regeneration, we performed wound-
healing assays. In accordance with delayed hair regeneration, Sox4cKO mice also 
displayed a significant delay in replenishing the epidermis after wounding (Figure 21C), 
indicating a general delayed response of Sox4-deficient skin to proliferative stimuli. 
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Figure 21. Absence of Sox4 delays skin regeneration.
(A) Sox4, Sox11 and Sox12 qPCR along plucking-induced 
anagen. N=2-3 mice per condition.
(B) (Lef t) Hair regeneration dynamics in Sox4WT and Sox4cKO 
mice. Initial pluck area is delimitated by white dashed lines. 
(Right) Quantif ication of  hair regeneration at D12 af ter 
plucking, as means of  regenerated area (%) with respect to 
that of  initial plucked area. 
(C) (Top) Wound healing in Sox4WT and Sox4cKO mouse skin at 
D0 and D8 af ter wounding. Dashed circles mark the initial 
wound area. (Bottom) Quantif ication of  remaining wound area 
(% of  initial) at the indicated days 
Genotype and number (N) of  mice are shown; p values were 
obtained with Student’s t test. Depicted is mean and SEM.
 
 
IX. Defective HFSC activation and DNA damage accumulation upon plucking in the 
absence of Sox4 
 
In order to understand the cause of the delayed hair regeneration and wound-
healing in Sox4cKO mice, we tested the ability of HFSCs to regenerate the skin after 
plucking (Keyes et al., 2013; Muller-Rover et al., 2001). To this end, we performed skin 
histology and IHC analysis 12 days after plucking. We noted a significant reduction in hair 
follicle length, epidermal thickness and dermis size in Sox4cKO compared to Sox4WT, 
indicating reduced hair cycle induction in the absence of Sox4 (Figure 22A and B) (Flores 
et al., 2005; Keyes et al., 2013; Muller-Rover et al., 2001). Simultaneously, there was an 
overall decrease in the number of proliferating cells, as evidenced by Ki67 staining, in the 
differentiating areas of the skin such as the IFE, the hair bulb and the hair progeny 
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compartments, further supporting limited induction of hair cycling (Figure 22C and D). This 
was accompanied by an increase in the percentage of γH2AX-positive cells (Figure 22E 
and F) and p53-positive cells (Figure 22G and H). To confirm that the delayed HFSC 
activation was a cell-autonomous event, we extracted keratinocytes from adult mice and 
cultured them in clonogenic conditions. After 2 weeks in culture we observed a significant 
reduction in the number of big, differentiated colonies in keratinocytes depleted of Sox4 
(Figure 23) 
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Figure 22. Requirement of Sox4 for normal HFSC activation during hair regeneration.
(A) H&E staining in Sox4WT and Sox4cKO mouse back skin sections, at D12 af ter plucking. Skin regions are delimitated 
with dashed lines. 
(B) Hair follicle length, epidermis thickness and dermal size f rom the experiment described in A. 
(C-H) (Lef t) Ki67 (C), γH2AX (E) and p53 (G) IHCs on back skin sections f rom Sox4WT and Sox4cKO mice, at D12 post-
pluck. Insets show magnif ication. Abbreviations are: Prog, Hair Progeny; IFE, Interfollicular Epidermis; JZ, Junctional 
Zone; HF, Hair Follicle; Bulb, Hair Bulb. Scale bars are indicated; depicted is a representative picture of  5 mice per 
genotype. (Right) Ki67 (D), γH2AX (F) and p53 (H) positive cells (% in the indicated compartments) found 12 days af ter 
plucking. 
Number of  mice (n) is 5 mice per genotype unless indicated. Student’s t test was used. Depicted is average and SEM. 
Scale bars are included within graphs.
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These results indicate that Sox4 is necessary for the skin response to proliferative 
stimuli such as hair plucking, suggesting an impaired ability of stem cells to exit 
quiescence and regenerate the hair (Flores and Blasco, 2009; Flores et al., 2005; Keyes 
et al., 2013). 
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Figure 23. Requirement of Sox4 for 
normal HFSC activation during hair 
regeneration (II).
(Lef t) Micrographs of  dif ferentiating primary 
keratinocytes under bright f ield 
(magnif ication is 20X) and Giemsa-stained 
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6 plates f rom 2 mice per genotype (n=2). 
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X. Sox4 is required for the coordinated initiation of differentiation and proliferative 
programs upon HFSC activation 
 
To dissect the molecular pathways underlying the delayed hair regeneration in 
Sox4-deficient skin, we performed microarray-based gene expression profiling in anagen 
skin 12 days after plucking, when Ki67 peaks (Figure 24A and B). Given that Sox4 acts as 
a transcriptional activator (van de Wetering et al., 1993), we first focused in the genes 
negatively regulated in Sox4cKO mice. A stringent (FDR<0.15) analysis revealed 12 
differentially expressed genes (DEGs) between Sox4WT and Sox4cKO mouse skin 
undergoing hair regeneration (Table 4).  
Among them, Sox4 was the most downregulated gene (log2FC=4.87; ≈30-fold 
decrease) (Figure 24B and Table 4), thus validating the microarray. The rest of DEGs 
were involved in nervous system development, heart function, cytoskeleton remodeling 
and cancer, as determined by GO studies (Table 4). All these processes have been 
previously linked to Sox4 (Vervoort et al., 2013) and therefore provide a biologically-
relevant quality control. 
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Figure 24. Sox4 skin deficiency hampers the 
induction of proliferative and differentiation 
pathways during the plucking response.
(A) Ki67 dynamics along plucking assessed by 
IHC. 
(B) Heatmap displaying the top-50 DEGs, of  
Sox4WT and Sox4cKO mice undergoing hair 
regeneration (D12 af ter pluck). Indicated is the 
genotype (n=6 mice per genotype f rom two 
independent experiments). Gene symbols are 
shown, and relative expression (log2FC) is scaled 
in color-code (indicated).
(C) Enrichment plots f rom the Sox4 (Liao et al., 
2008), Sox9 and Sox5 signatures (Transfac) as 
assessed by GSEA.
(D) Heatmaps of  the top-twenty genes with 
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repair (middle) and HFSC activation (right) 
pathways, as inferred f rom GSEA. Relative 
expression levels are color-coded (indicated).
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Symbol Name log2FC p value Annotated Diseases GO ID
Biological/Molecular GO 
term
GO:0001841 neural tube formation
GO:0002328 pro-B cell differentiation
GO:0003211 cardiac ventricle formation
GO:0006355
regulation of transcription, DNA-
dependent
GO:0008284
positive regulation of cell 
proliferation
GO:0035019 somatic stem cell maintenance
GO:0090263
canonical Wnt signaling 
pathway
GO:0003723 RNA binding
GO:0005515 protein binding
GO:0008270 zinc ion binding
GO:0003824 catalytic activity
GO:0005515 protein binding
GO:0008195
phosphatidate phosphatase 
activity
GO:0007015 actin filament organization
GO:0001570 vasculogenesis
GO:0001843 neural tube closure
GO:0003143
embryonic heart tube 
morphogenesis
GO:0006355
regulation of transcription, DNA-
dependent
GO:0006367
transcription initiation from RNA 
polymerase II promoter
Tead2
TEA Domain 
Family Member 
2
1,017 5,48E-05
Patulous eustachian tube, Alpha-
mannosidosis, Plasmodium 
falciparum malaria, Pharyngitis, 
Neuronitis
nervous system development
Sox4
SRY (Sex 
Determining 
Region Y)-Box 
4
4,872 9,01E-13
Splenic abscess, Esophageal varix, 
Hypersplenism, Portal hypertension, 
Wiskott-aldrich syndrome, Liver 
cirrhosis, Hypertension, 
Esophagitis, Colorectal cancer, 
Gastric cancer, Endotheliitis, Breast 
cancer
Evl
Neuronitis, Splenic marginal zone 
lymphoma, Adenoid cystic 
carcinoma, Endometrial 
adenocarcinoma, Ependymoma, 
Mantle cell lymphoma, Colorectal    
cancer, Melanoma, Hepatitis, Breast 
cancer, Lung cancer, Prostate 
cancer, Obesity, Myeloma, 
Hepatocellular carcinoma, 
Adenocarcinoma, Glioblastoma, 
Medulloblastoma, Bladder 
carcinoma  
GO:0007166 cell surface receptor signaling 
pathway
Ena/VASP-Like 
Protein 1,07E-051,423
GO:0008154 actin polymerization or 
depolymerization
GO:0007411 axon guidance
GO:0007399
2,47E-082,231
Mex-3 RNA 
Binding Family 
Member A
Mex3a
Melanoma, Pancreatitis
BC005764    
(Prg-2, 
Lpppr3 )
Plasticity-
Related Gene 2 
Protein Lipid 
Phosphate 
Phosphatase-
Related Protein 
Type 
1,923 6,24E-07
NA
Zinc Finger 
Protein 184 
(Kruppel-Like)
Zfp184       
(Znf184)
transcription, DNA-dependentGO:0006351
GO:0006355
regulation of transcription, DNA-
dependent
Choriocarcinoma, Schizophrenia3,97E-051,261
Table 4. Annotated ranked list of genes significantly downregulated in Sox4cKO vs. Sox4WT mice undergoing hair regeneration 12 days after 
plucking.
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Next, we performed Gene Set Enrichment Analysis (GSEA) to gain insights into 
the biological significance of the DEGs. GSEA revealed significant alteration (FDR<0.05) 
of 92 signaling pathways (extracted from the KEGG, Reactome and NCI repositories) in 
Sox4WT vs. Sox4cKO mice (Table 5).  We confirmed a Sox4 signature in the microarray by 
analyzing genes identified by Liao and colleagues (Liao et al., 2008) (Figure 24C; 
FDR=0.017). This group of gene sets showed downregulation in pathways controlling 
progression throughout cell cycle, epidermal stem cell activation and DNA repair (24 D 
and E; Table 5). These included critical mitotic regulators such as CDK4, Bub1, Ccnb1; 
genes of the DNA replication origin assembly, such as Mcm2, 5 and 7; and centrosome 
maturation genes such as Mad2l1 and Plk1 (Figure 24D and E). We also found 
downregulation of DNA repair and replicative stress pathways in Sox4cKO mice undergoing 
hair regeneration, in agreement with the observed DNA damage accumulation upon 
plucking (Figure 24D and E). Interestingly, several of the gene sets significantly 
downregulated in the absence of Sox4 have been shown crucial for proper hair follicle 
cycling and activation/differentiation of HFSCs (Berta et al., 2010; Lien et al., 2014; Nowak 
et al., 2008; Oro and Higgins, 2003). In particular, we found downregulation in the Myc 
and Hedgehog pathways, in support of the previously shown delayed hair follicle 
activation (Figure 24D and E). We further confirmed a defective HFSC function by testing 
a home-made list of genes obtained from the Sox9 signature in the Transfac repository. 
We observed a significant (FDR=0.029) overlap among genes regulated by Sox9 and 
those specifically downregulated in Sox4cKO mice undergoing anagen in contrast to 
Sox4WT controls. We used the Sox5 signature as a negative control, which did not show 
significant variation in our microarray (Figure 24C). Finally, we compared our microarray 
data with the plucking-induced, Wnt-upregulated, β-catenin-sensitive gene signature 
obtained by Lien and colleagues, a bona fide set of genes governing HFSC activation 
(Lien et al., 2014). Interestingly, we found a significant downregulation (FDR=0.028) of 
this set of genes in Sox4-depleted HFSC 12 days after plucking, when compared to their 
WT controls (Figure 24D and E). This overlapping regulation points out to a cooperation of 
β-catenin and Sox4 in regulating target genes relevant for Wnt-induced HFSC activation 
and normal hair regeneration. 
Altogether, these results demonstrate that absence of Sox4 in skin results in 
delayed epidermal stem cell activation and subsequent deficient induction of proliferative 
and differentiation pathways, concomitant with defects in DNA damage repair and 
therefore pointing out to Sox4 as a crucial regulator of pathways that master the exit of 
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epidermal stem cell quiescence. The coalescence of Sox4-mediated transcription with β-
catenin targets further confirms the importance of Sox4 in governing the hair regeneration 
process. 
 
Gene Set Name # Genes NES FDR q-val Source Status
DNA REPLICATION 35 23.419.375 < 1E-05 KEGG DOWN 
CELL CYCLE 108 22.575.436 < 1E-05 KEGG DOWN 
CELL CYCLE, MITOTIC 317 2.670.456 < 1E-05 REACTOME DOWN 
M PHASE 94 25.053.108 < 1E-05 REACTOME DOWN 
MITOTIC PROMETAPHASE 90 24.785.168 < 1E-05 REACTOME DOWN 
G2/M CHECKPOINTS 45 24.457.316 < 1E-05 REACTOME DOWN 
ACTIVATION OF THE PRE-REPLICATIVE COMPLEX 29 23.832.464 < 1E-05 REACTOME DOWN 
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS 35 23.366.392 < 1E-05 REACTOME DOWN 
DNA STRAND ELONGATION 29 22.902.646 < 1E-05 REACTOME DOWN 
PLK1 SIGNALING EVENTS 40 25.397.267 < 1E-05 NCI DOWN 
FANCONI ANEMIA PATHWAY 42 2.312.326 < 1E-05 NCI DOWN 
ATR SIGNALING PATHWAY 37 22.004.871 < 1E-05 NCI DOWN 
ELONGATION AND PROCESSING OF CAPPED TRANSCRIPTS 129 21.529.381 6.39E-05 REACTOME DOWN 
E2F MEDIATED REGULATION OF DNA REPLICATION 37 2.168.428 6.74E-05 REACTOME DOWN 
EXTENSION OF TELOMERES 22 21.894.016 7.14E-05 REACTOME DOWN 
E2F TRANSCRIPTIONAL TARGETS AT G1/S 22 21.906.655 7.58E-05 REACTOME DOWN 
FORMATION AND MATURATION OF MRNA TRANSCRIPT 146 21.985.574 8.09E-05 REACTOME DOWN 
LOSS OF PROTEINS REQUIRED FOR INTERPHASE MICROTUBULE ORGANIZA 81 22.046.125 8.67E-05 REACTOME DOWN 
G2/M TRANSITION 97 22.255.423 9.34E-05 REACTOME DOWN 
DOUBLE-STRAND BREAK REPAIR 31 22.309.527 1.01E-04 REACTOME DOWN 
HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION-INDEPENDENT D 26 22.312.896 1.10E-04 REACTOME DOWN 
LOSS OF NLP FROM MITOTIC CENTROSOMES 81 22.381.098 1.21E-04 REACTOME DOWN 
HOMOLOGOUS RECOMBINATION REPAIR 26 22.718.346 1.35E-04 REACTOME DOWN 
CENTROSOME MATURATION 90 22.736.535 1.52E-04 REACTOME DOWN 
ASSEMBLY OF THE RAD50-MRE11-NBS1 COMPLEX AT DNA DOUBLE-STRAND 16 20.962.038 1.58E-04 REACTOME DOWN 
CELL CYCLE CHECKPOINTS 116 21.012.824 1.65E-04 REACTOME DOWN 
ATM MEDIATED PHOSPHORYLATION OF REPAIR PROTEINS 17 21.284.003 1.72E-04 REACTOME DOWN 
LAGGING STRAND SYNTHESIS 19 21.374.292 1.80E-04 REACTOME DOWN 
ELONGATION OF INTRON-CONTAINING TRANSCRIPTS AND CO-TRANSCRIPTIO 129 21.416.466 1.89E-04 REACTOME DOWN 
AURORA B SIGNALING 39 20.790.722 2.09E-04 NCI DOWN 
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN TC-NER 16 20.626.438 2.23E-04 REACTOME DOWN 
E2F-ENABLED INHIBITION OF PRE-REPLICATION COMPLEX FORMATION 15 20.684.686 2.32E-04 REACTOME DOWN 
MRN COMPLEX RELOCALIZES TO NUCLEAR FOCI 16 20.856.543 2.41E-04 REACTOME DOWN 
ATM MEDIATED RESPONSE TO DNA DOUBLE-STRAND BREAK 17 20.860.016 2.50E-04 REACTOME DOWN 
BARD1 SIGNALING EVENTS 27 20.733.442 3.50E-04 NCI DOWN 
DNA REPLICATION 96 20.064.106 3.89E-04 REACTOME DOWN 
G1/S TRANSITION 109 2.009.477 4.02E-04 REACTOME DOWN 
CYTOSOLIC TRNA AMINOACYLATION 27 20.106.726 4.15E-04 REACTOME DOWN 
METABOLISM OF NON-CODING RNA 17 20.236.602 4.30E-04 REACTOME DOWN 
DNA REPAIR 98 19.992.706 4.53E-04 REACTOME DOWN 
GAP-FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG-NER 16 19.747.477 6.90E-04 REACTOME DOWN 
HOMOLOGOUS RECOMBINATION 27 20.180.893 0.001285787 KEGG DOWN 
PYRIMIDINE METABOLISM 89 2.018.695 0.001353652 KEGG DOWN 
MISMATCH REPAIR 22 19.752.159 0.001968444 KEGG DOWN 
DNA REPLICATION PRE-INITIATION 75 18.913.058 0.002422943 REACTOME DOWN 
APC/C:CDC20 MEDIATED DEGRADATION OF CYCLIN B 30 18.631.127 0.003491783 REACTOME DOWN 
MITOTIC SPINDLE CHECKPOINT 22 18.565.638 0.003697891 REACTOME DOWN 
FOXM1 TRANSCRIPTION FACTOR NETWORK 39 19.572.923 0.0037972662 NCI DOWN 
APC-CDC20 MEDIATED DEGRADATION OF NEK2A 27 18.275.056 0.004728567 REACTOME DOWN 
CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION 26 18.290.805 0.004823893 REACTOME DOWN 
ABC TRANSPORTERS - GENERAL 41 -20.396.116 0.005750482 KEGG UP 
FORMATION OF THE EARLY ELONGATION COMPLEX 32 1.806.907 0.005861847 REACTOME DOWN 
BASE EXCISION REPAIR 17 18.014.127 0.006018174 REACTOME DOWN 
APC/C-MEDIATED DEGRADATION OF CELL CYCLE PROTEINS 84 17.948.378 0.006361603 REACTOME DOWN 
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC/C REQUIRED FOR THE O 21 17.887.087 0.006581755 REACTOME DOWN 
RHOA SIGNALING PATHWAY 43 -20.495.057 0.007478651 NCI UP 
Table 5. Ranked list of  gene sets signif icantly changed in Sox4cKO vs. Sox4WT mice undergoing hair regeneration 12 
days af ter plucking.  
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Gene Set Name # Genes NES FDR q-val Source Status
HEDGEHOG SIGNALING PATHWAY 53 1.873.602 0.007613374 KEGG DOWN 
BASAL CELL CARCINOMA 55 18.676 0.007957148 KEGG DOWN 
AMINOACYL-TRNA BIOSYNTHESIS 42 1.851.659 0.008033624 KEGG DOWN 
SYSTEMIC LUPUS ERYTHEMATOSUS 87 18.603.351 0.00830677 KEGG DOWN 
GENE EXPRESSION 353 17.621.422 0.008675053 REACTOME DOWN 
VALIDATED TARGETS OF C-MYC TRANSCRIPTIONAL ACTIVATION 78 18.829.532 0.0091759 NCI DOWN 
HEDGEHOG SIGNALING EVENTS MEDIATED BY GLI PROTEINS 47 18.652.664 0.009426778 NCI DOWN 
INACTIVATION OF APC/C VIA DIRECT INHIBITION OF THE APC/C COMPLEX 21 1.746.477 0.010122311 REACTOME DOWN 
BASE EXCISION REPAIR 33 18.169.132 0.010572486 KEGG DOWN 
IL23-MEDIATED SIGNALING EVENTS 37 -19.667.697 0.011410583 NCI UP 
E2F TRANSCRIPTION FACTOR NETWORK 67 18.426.008 0.011725595 NCI DOWN 
GLOBAL GENOMIC NER (GG-NER) 34 1.729.057 0.011841513 REACTOME DOWN 
GLUCOSE METABOLISM 77 -18.421.031 0.014822196 REACTOME UP 
CYTOCHROME P450 - ARRANGED BY SUBSTRATE TYPE 50 -18.640.511 0.017167443 REACTOME UP 
PHASE 1 - FUNCTIONALIZATION OF COMPOUNDS 71 -18.427.429 0.018527746 REACTOME UP 
AURORA A SIGNALING 29 17.860.239 0.019656735 NCI DOWN 
ACTIVATION OF APC/C AND APC/C:CDC20 MEDIATED DEGRADATION OF MITO 77 16.652.274 0.02164067 REACTOME DOWN 
NUCLEOTIDE EXCISION REPAIR 40 1.751.457 0.022095194 KEGG DOWN 
ATM PATHWAY 32 17.544.352 0.024574187 NCI DOWN 
MITOCHONDRIAL TRNA AMINOACYLATION 26 16.489.309 0.024760392 REACTOME DOWN 
HDL-MEDIATED LIPID TRANSPORT 26 -18.641.241 0.025751164 REACTOME UP 
NUCLEOTIDE EXCISION REPAIR 50 16.393.281 0.026672386 REACTOME DOWN 
CONVERSION FROM APC/C:CDC20 TO APC/C:CDH1 IN LATE ANAPHASE 19 16.323.775 0.027763184 REACTOME DOWN 
UREA CYCLE AND METABOLISM OF AMINO GROUPS 27 1.704.583 0.029192088 KEGG DOWN 
COLLAGEN-MEDIATED ACTIVATION CASCADE 16 16.171.777 0.030529834 REACTOME DOWN 
THYROID CANCER 27 17.080.088 0.030887974 KEGG DOWN 
GENERATION OF SECOND MESSENGER MOLECULES 20 15.895.758 0.036932748 REACTOME DOWN 
M/G1 TRANSITION 61 15.907.022 0.037230276 REACTOME DOWN 
APC/C:CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS 74 15.929.469 0.037267175 REACTOME DOWN 
FGFR4 LIGAND BINDING AND ACTIVATION 15 -18.798.758 0.039966363 REACTOME UP 
ASSEMBLY OF THE PRE-REPLICATIVE COMPLEX 61 15.754.787 0.040402573 REACTOME DOWN 
METABOLISM OF BILE ACIDS AND BILE SALTS 47 -17.318.394 0.044718016 REACTOME UP 
MELANOGENESIS 100 16.441.392 0.04555292 KEGG DOWN 
P53 SIGNALING PATHWAY 65 16.359.637 0.04618583 KEGG DOWN 
SELENOAMINO ACID METABOLISM 22 16.455.731 0.04809926 KEGG DOWN 
FORMATION OF RNA POL II ELONGATION COMPLEX 43 15.488.114 0.049070586 REACTOME DOWN 
Table 5 (Cont.). Ranked list of  gene sets signif icantly changed in Sox4cKO vs. Sox4WT mice undergoing hair 
regeneration 12 days af ter plucking.  
 
 
XI. Sox4 deficiency prevents chemically-induced skin carcinogenesis  
 
We have shown that Sox4 levels correlate with resistance to spontaneous 
carcinogenesis in hypomorphic Sox4lox/lox mice. Moreover, Sox4-deficient keratinocytes 
are resilient to HFSC activation when facing proliferative stimuli, and several of the Sox4-
regulated genes in our microarray profiling point to severe impairment of cell division 
capacity of cells. We therefore speculated that Sox4-deficient keratinocytes could be 
resistant to oncogenic signals required for rapid proliferation, thereby preventing 
expansion of malignant cells during skin carcinogenesis. To test that, we performed a two-
step chemically induced carcinogenic protocol. We treated the mice with a single dose of 
DMBA and administered TPA twice weekly during 15 additional weeks in order to promote 
expansion of cells bearing oncogenic mutations. We monitored tumor burden once a week 
during a total of 35 weeks after the first DMBA administration (Figure 25A). We observed 
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that the onset of papillomas was delayed in Sox4cKO mice after DMBA/TPA administration 
(Figure 25B). Moreover, the average number of tumors per mouse was notably reduced 
across the duration of experiment (Figure 25B and 26A and B). Of note, most of the 
papillomas that appeared in Sox4cKO mice regressed upon TPA withdrawal, while up to 
30% of the tumours formed in Sox4WT became independent of TPA administration and 
progressed (Figure 25B and Figure 26A and B). In addition, Sox4-depleted mice did not 
display any papilloma bigger than 6mm after 30 weeks of treatment, in contrast to more 
than 80% of Sox4WT mice (Figure 26B).  
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Figure 25. Absence of Sox4 prevents chemically-induced tumorigenesis
(A) Schematic representation of  the two-step chemically-induced carcinogenesis protocol. Red arrows denote the 
twice-weekly administration of  TPA during the f irst 15 weeks of  the treatment. 
(B) Average number of  papillomas, stratif ied by size (colour-coded), at the indicated weeks af ter the TPA/DMBA 
treatment in Sox4WT (lef t) and Sox4cKO (right) mice. Red arrowhead marks the end of  the TPA treatment.  
 
In order to rule out possible non-cell autonomous effects of Sox4 in chemically 
induced skin carcinogenesis, we performed in vitro transformation protocols. For that, we 
assayed Sox4lox/lox and Sox4+/+ Mouse Embryonic Fibroblasts (MEFs) previously 
transduced with Adeno-Cre viruses to induce recombination of the KI allele (hereafter 
Sox4lox/lox; AdCre and Sox4+/+; AdCre MEFs). In order to transform the MEFs, we further 
transduced them with HRasG12V and E1A oncogenes, and subsequently plated them at 
a very low density to quantify appearance of transformed foci. Sox4lox/lox; AdCre MEFs 
showed a dramatically reduced foci formation compared to the Sox4+/+ controls, indicative 
of reduced transformation ability (Figure 26C). These results indicate that the impairment 
of tumorigenesis in the absence of Sox4 is cell autonomous. 
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We also studied carcinogenesis in Sox4HET and Sox4 hypomorphic (Sox4lox/lox) 
mice. We observed a good correlation between Sox4 gene dosage and tumour burden, as 
assessed by the total number of tumours and the percentage of mice bearing big tumours 
(Figure 26B). These results point out to Sox4 as a gene necessary for skin cell 
transformation and tumorigenesis, in agreement with the fact that Sox4 is upregulated in 
many different cancer types. 
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Figure 26. Absence of Sox4 prevents chemically-induced tumorigenesis
(A) Representative pictures of  Sox4WT (top) and Sox4cKO mice (bottom), 30 weeks af ter the DMBA application. 
(B) Average number of  tumors (Lef t; Student’s t test, all groups were compared to Sox4WT) and percentage of  mice 
bearing tumors >6mm (Lef t: two-tailed Student’s t test; right, Fisher’s exact test, compared to Sox4WT). 
(C) (Lef t) Colony-forming assay using transformed Sox4+/+ and Sox4lox/lox MEF, previously transduced with AdCre and 
further transduced with Ras-IRES-E1A. (Right) 100mm dishes seeded with 2x103 cells grown for 2 weeks and stained 
with Giemsa. (Right) Number of  transformed foci >2mm per mouse. Two-tailed Student’s t test.  
 
 
XII. A resistance to TPA-induced proliferation limits the skin tumour burden in the 
absence of Sox4 
 
Having demonstrated the essential role that Sox4 plays on keratinocyte 
transformation, we wanted to understand the mechanism by which this protein could exert 
its function during carcinogenesis. Given that papilloma burden in Sox4WT mice peaks 
between 6 and 8 weeks after TPA/DMBA administration (Figure 25), we decided to 
sacrifice a group of animals after 6 weeks of treatment for histological examination of skin. 
Interestingly, we found a strong reduction in the percentage of proliferating cells, as 
assessed by Ki67 staining, at the IFE of Sox4cKO mice (Figure 27A and B). Accordingly, 
these mice showed a reduced thickening of this compartment and a reduced hair follicle 
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length, indicating that Sox4 is needed for cell expansion upon mitogenic stimulation. We 
also studied the levels and distribution of phosphorylated Histone-3 (P-H3) by IHC in 
equivalent regions of benign lesions (collected at 30 weeks of treatment) from Sox4WT and 
Sox4cKO mice, as determined from the distribution of the Loricrin and Cytokeratin-6 
markers (Figure 27C). We observed a notable reduction in the amount of cells positive for 
P-H3. In addition, the majority of P-H3-positive cells in Sox4cKO mouse skin showed a 
dotted pattern, indicating that these cells could not progress through the cell cycle beyond 
G2 (Goto et al., 1999) (Figure 27C). These findings are in line with defective activation 
and proliferation of HFSCs upon stimulation that we have observed both through IHC and 
microarray profiling, which include downregulation of many genes required for cell 
division. All these results provide a molecular proof of tumour suppression mediated by 
loss of Sox4 by preventing entry into cell cycle and account for the reduced tumour 
formation abilities in Sox4-reduced contexts.  
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Figure 27. Defective proliferation in
Sox4cKO mice upon TPA stimulation
and along cellular transformation.
(A) Ki67 IHC in skin f rom Sox4WT and
Sox4cKO mice, 6 weeks after initiation of
DMBA/TPA treatment. Note the reduced
Ki67-positive cells in Sox4-depleted
mice.
(B) IFE thickness and hair follicle length
af ter 6 weeks of TPA treatment.
(C) Loricrin, Cytokeratin 6 (CK6), p53
and phospho-Histone 3 (P-H3) IHC in
benign lesions af ter 30 weeks of TPA
treatment, in Sox4WT and Sox4cKO mice.
Insets show magnif ication; yellow
arrowheads, pan-nuclear P-H3-positive
cells; red arrowheads, dotted P-H3.
N=number of mice per genotype.
Student’s t test was used for comparison.
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XIII. DMBA/TPA treatment favours melanocytic lesions in the absence of Sox4 
 
Melanoma is the only tumour type in which reduced expression or genomic loss of 
Sox4 has been consistently reported in correlation with increased malignancy hitherto 
(Jafarnejad et al.; Jafarnejad et al.; Zhang and Li, 2012). We have shown that Sox4cKO 
mice have reduced susceptibility to skin tumorigenesis. Nevertheless, we noted that upon 
TPA/DMBA stimulation a number of melanocytic lesions started to appear in mice from all 
the studied genotypes. However, both the rate of growth and the number of such 
lentiginous lesions were notably increased in Sox4cKO and Sox4 hypomorphic Sox4lox/lox 
mice. These melanocytic hyperplasias stopped growing after TPA withdrawal, according 
to the correlation of melanocytic growth with skin stress (Cui et al., 2007). However, in 
reduced Sox4 expression contexts (such as in Sox4cKO, hypomorphic Sox4lox/lox and, 
though to a lesser extent, in Sox4HET mice) these lesions progressed in size and number 
in good correlation with Sox4 dosage (Figure 28). Interestingly, we even detected one 
malignant melanoma with metastasis in the axilar lymph nodes of a Sox4HET mouse 
(Figure 28). This paradoxical result indicates that reduced Sox4 expression can be causal 
of melanoma initiation and/or progression, in agreement with the observation that Sox4 
can behave as a tumour suppressor in melanoma despite it prominent role as oncogene 
in most cellular contexts (Cai et al.; Jafarnejad et al.; Jafarnejad et al.; Zhang and Li, 
2012) (Figure 28).  
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Figure 28. Reduced Sox4 expression 
levels favour the appearance of 
melanoma under forced proliferative 
stimulus.
(Lef t) Melanocytic lesions in DMBA/TPA-
treated Sox4cKO mouse skin (blue
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Discussion 
“(…) Cuántas veces me pregunto si esto no es más que escritura, en un tiempo en que 
corremos al engaño entre ecuaciones infalibles y máquinas de conformismos. Pero 
preguntarse si sabremos encontrar el otro lado de la costumbre o si más vale dejarse 
llevar por su alegre cibernética, ¿no será otra vez literatura? Rebelión, conformismo, 
angustia, alimentos terrestres, todas las dicotomías: el Yin y el Yang, la contemplación 
o la Tatigkeit, avena arrollada o perdices faisandées, Lascaux o Mathieu, qué hamaca 
de palabras, qué dialéctica de bolsillo con tormentas en piyama y cataclismos de living 
room. El solo hecho de interrogarse sobre la posible elección vicia y enturbia lo 
elegible. Que sí, que no, que en ésta está... Parecería que una elección no puede ser 
dialéctica, que su planteo la empobrece, es decir la falsea, es decir la transforma en 
otra cosa. Entre el Yin y el Yang, ¿cuántos eones? Del sí al no, ¿cuántos quizá? Todo 
es escritura, es decir fábula. ¿Pero de qué nos sirve la verdad que tranquiliza al 
propietario honesto? (…)”. 
 
  Julio Cortázar. Rayuela, Cap. 1 
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I. Sox4 is dispensable for mES differentiation and iPS generation 
 
Mammalian embryonic development consists on the generation of specialised 
tissues composed of a variety of cells that arise from an original multipotent embryonic 
stem cell (Smith, 2001). Likewise, adult tisular homeostasis is maintained through input 
coming from the tissue stem cells that fuel with fresh cells those tissues that have lost 
their integrity during normal tissue homeostasis or wounding (Blanpain and Simons, 
2013). 
The dogma of the Waddington’s deterministic, irreversible epigenetic landscape 
along differentiation was first challenged when Gurdon demonstrated in the late 1950’s 
that it was indeed possible to revert a cell’s fate by means of nuclear transfer when he 
generated the first cloned organism, obtained from somatic cells (Gurdon et al., 1958). 
More than 40 years later, Yamanaka and colleagues achieved another milestone in the 
field of somatic nuclear reprogramming when they demonstrated that it was possible to 
revert a differentiated cell’s status to that of embryonic stem-like by transducing a 
differentiated cell with a cocktail of just four transcription factors. These induced-
pluripotent stem cells (iPS cells) were capable of giving rise to all the cellular lineages in a 
similar fashion to that of mES cells and therefore overcome the ethical issues that arise 
from the use of human embryonic stem cells (Takahashi et al., 2007; Takahashi and 
Yamanaka, 2006). 
However in nature, while stem cells specialize and differentiate they also lose part 
of their potency, and as so in adult organisms the so-called somatic (or adult) stem cells 
are uni-, bi-, or multi-potent, therefore being capable of giving rise to only few, but not all, 
cellular lineages, as opposed to embryonic stem cells (Wagers and Weissman, 2004). To 
prevent stem cell exhaustion, the other main feature of stem cells besides differentiation 
into specialised tissues through asymmetrical cell division is that they are also capable of 
self-renew through symmetrical division whereby they generate identical daughter cells 
that ensure a stable population of stem cells (Sharpless and DePinho, 2007). The 
decisions that govern the balance between self-renewal and differentiation are tightly 
controlled through the interaction of extrinsic cues (such as fluctuating environmental 
stimuli) with intrinsic mediators of the cell behaviour (such as chromatin remodelers and 
transcription factors) (Simons and Clevers, 2011). Among the above-mentioned intrinsic 
factors, the family of Sox proteins is known to play major roles in regulating processes 
associated to cell fate decisions (Lefebvre et al., 2007; Sarkar and Hochedlinger, 2013). 
Not surprisingly, some of the Sox factors also play crucial roles in the differentiation and 
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maintenance of somatic stem cells, such as Sox1 or Sox9 in neural and skin stem cells 
respectively (Nowak et al., 2008; Sarkar and Hochedlinger, 2013), or in the generation of 
iPS cells, such as Sox2 (Takahashi and Yamanaka, 2006).  
 
In this work we have focused our attention in Sox4, one of the poorest-studied Sox 
members in the context of adult tissues and embryonic/somatic stem cell biology (Sarkar 
and Hochedlinger, 2013). For that, we have generated mice bearing an excisable KI 
cassette that would allow us to track cells expressing Sox4 in vivo; the KI cassette was 
flanked by LoxP sites to functionally address the results of its ablation in adult organisms 
and stem cells (Figure 6). 
First of all, we have observed an upregulation of Sox4 mRNA expression levels in 
WT mES cells treated with retinoic acid to promote neuroectoderm differentiation inversely 
paralleled by a progressive reduction along acquisition of pluripotency (Figure 7A-C). 
These results were exciting, as they suggested that Sox4 could constitute a break during 
reprogramming. In this regard, promising results arising from high-throughput mRNA 
sequencing in iPS treated with 2i (naïve pluripotent cells) compared to FBS-treated cells 
(primed state) showed upregulation of Sox4 in primed iPS cells, suggesting indeed that 
this factor could represent an early trigger during the loss of pluripotency (Marks et al., 
2012). Taking advantage of our mouse model bearing a KI-excisable cassette at the Sox4 
locus, we first tested whether Sox4 could boost reprogramming. We actually observed 
decreased reprogramming efficiency in the absence of Sox4, but we obtained iPS cells 
depleted of Sox4 expression that besides displayed normal expression levels of 
pluripotency factors (Figure 7). Aiming to test whether Sox4 could be relevant during stem 
cell differentiation instead, we performed teratoma-mediated assays and detected 
contribution to all embryonic layers, indicating that Sox4 is largely dispensable at least 
during the first stages of mammalian embryonic development. These results go in line with 
the observation that Sox4-null embryos can develop until midgestation (E14.5) (Penzo-
Mendez, 2010; Schilham et al., 1996), in contrast to Sox2-null embryos, for example, 
whose development in severely impaired at the two-cell stage (Sarkar and Hochedlinger, 
2013). Interestingly, the reduction in reprogramming efficiency and the slightly reduced 
velocity of teratoma growth are suggestive of imperfect induction of proliferation, required 
for both reprogramming and differentiation, an effect that we later observed also in adult 
stem cells from the skin (see below). 
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II. Sox4 is required for normal adult tissue homeostasis 
 
We next sought to address the role of Sox4 in the adult organism. We generated a 
KI cassette targeted to the Sox4 locus in order to achieve expression of a reporter protein 
driven by the endogenous Sox4 promoter. This would allow us to in vivo track cells 
expressing Sox4, by means of direct GFP or Luciferase detection. Unfortunately, we could 
not detect any GFP-positive cell, indicative of interference of the KI cassette with its own 
expression; most likely this was due to decreased mRNA stability due to the insertion of 
the distal LoxP site within the 3’-UTR region or rather owing to the IRES sequence 
(decreased translation was not likely, given that we detected the expression changes at 
the mRNA level, see below). Nevertheless, we observed a notable reduction in the 
Mendelian proportions at birth of mice from the Sox4lox/lox genotype likely due to mother’s 
disregard after smaller pups, as observed in other settings (Ortega-Molina et al., 2012) or 
decreased fitness of these pups; we could confirm that these mice were indeed 
hypomorphic and bear reduced Sox4 levels across tissues by qPCR (Figure 12). We took 
advantage of this peculiarity and obtained the first viable adult mouse model with reduced 
Sox4 levels in adult tissues. This allowed us demonstrate for the first time that moderately 
decreased Sox4 levels allow the progression throughout embryogenesis and produces 
viable organisms, in contrast to full abrogation of Sox4 (Bhattaram et al., 2010; Schilham 
et al., 1996); interestingly, Sox4 global downregulation leads to an earlier onset of several 
age-related pathologies, pointing out towards a prominent role for Sox4 in maintaining 
proper adult tissue homeostasis, beyond its roles during embryogenesis. This is of great 
interest, as before the publication of this thesis there was a recognised vast lack of 
knowledge with regard to the functions of Sox4 in adult tissues (Sarkar and Hochedlinger, 
2013); so far the results of Sox4 abrogation had only been addressed either during 
embryonic development or in haematopoietic and lymphoid cells obtained from Sox4-null 
foetal-liver cells or thymic cultures (Schilham et al., 1997); only recently conditional 
deletion in lymphocytes (Kuwahara et al., 2012; Malhotra et al., 2013; Sun et al., 2013), 
and in developing kidney and retina have been achieved so far (Huang et al., 2013; Jiang 
et al., 2013). 
A marked reduction was observed in the mean and maximum lifespan of Sox4lox/lox 
mice when compared to WT cohorts. Interestingly, we found decreased cancer-associated 
pathologies (20% of mice) in these mice when compared to WT mice at the humane end 
point, meaning that they died because of degenerative lesions rather than cancer, as 
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opposed to 80% of WT mice (Figure 10 and Table 3). Among the most prominent findings 
associated to ageing, hypomorphic Sox4 mice presented bone frailty due to decreased 
bone mineral density. This is an interesting result, according to previous reports showing 
that Sox4 is expressed in bone and positively regulated through parathyroid hormone 
signalling specifically in cultured osteoblasts (Reppe et al., 2000). In addition, human 
patients suffering from osteopetrosis secondary to hyperparathyroidism condition show 
increased Sox4 mRNA expression as assessed through microarray profiling of transiliacal 
bone biopsies; interestingly, a two-year follow-up analysis in one of the patients who 
undertook surgical removal of the parathyroid gland showed a reversion to normal levels 
of bone remodelling parameter, including Sox4, in response to normalised PTH levels 
(Reppe et al., 2006). Moreover, Sox4 haploinsufficiency in mice resulted in decreased 
bone mineral density and reduced trabecular mesh, as seen by DEXA and micro-
computerised tomography (µCT), due to a specific defect in osteoblast-mediated bone 
remodelling. Upon culture of calvarian osteoblasts in the context of Sox4 
haploinsufficiency or siRNA-mediated downregulation of Sox4, the authors demonstrated 
reduced proliferation and differentiation defects in osteoblast-specific markers such as 
osterix and osteocalcin in a Runx2-independent manner. The differences in BMD grew 
bigger in old mice, in support of a age-related progressive loss of proper bone 
homeostasis (Nissen-Meyer et al., 2007). The connection of bone loss with age in a Sox4-
dependent manner has further been proven in post-menopausal women through 
association studies (Duncan et al., 2011; Jemtland et al., 2011), providing exciting insights 
into possible development of treatments for this type of osteoporosis, and Sox4 
hypomorphic mice can be of great use in research in this topic, given that it can model this 
human condition in a closer fashion to what happens in the real situation. 
We also observed other age-associated pathologies and biomarkers such as 
increased incidence of dilated cardiomyopathy, pyometra and hepatic failure, together 
with shorter PBMC telomere length in Sox4lox/lox mice. There is a reminiscence of the 
vastly-characterised heart-associated defects during embryonic development in the 
absence of Sox4 with the incidence of cardiomyopathy in Sox4lox/lox mice (Paul et al., 
2013; Penzo-Mendez et al., 2007; Schilham et al., 1996; Ya et al., 1998). It is tempting to 
think of a possible function for Sox4 in the homeostasis of the adult heart, paralleling the 
prominent role that this protein exerts during heart morphogenesis. The impact of Sox4 in 
different cell types and in cardiac extracellular matrix remodelling during embryonic 
development could in our hypomorphic mice either result in congenital, non-lethal defects 
that only become evident with age or rather a manifestation of a role for Sox4 in adult 
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heart homeostasis (Paul et al., 2013), an interesting subject of study in the future. The 
presence of pyometra is also an exciting observation, given its marked association to 
progressive degeneration of the uterine wall with age (Verstegen J, 2008). Given that 
Sox4 expression in adult female mice has been found in correlation with oestrus, we 
cannot discriminate between a side effect of possible hormonal deregulation in the 
presence of reduced Sox4 levels, or a decline in the integrity of the uterine wall (Hunt and 
Clarke, 1999). There are no studies showing correlation of liver function with Sox4 thus 
far, with the exception of the increased Sox4 expression found in tumours (Hur et al., 
2010; Liao et al., 2008), therefore we speculate that increased hepatic failure could be, in 
principle, secondary to the onset of a general degenerative process and progressive loss 
of cellular fitness overall. An extremely exciting result to us was the correlation of the 
decreased survival with the reduced mean telomere length in peripheral blood (Figure 11). 
Telomere length is one of the most acknowledged molecular biomarkers of ageing, given 
the correlation of replicative age with telomere erosion (Canela et al., 2007; Lopez-Otin et 
al., 2013; Vera et al., 2012) and the causality of shortened telomeres in the accelerated 
onset of age-related pathologies, as ascertained from studies in telomerase-deficient mice 
and telomerase reintroduction or reactivation and its impact on age and lifespan 
(Bernardes de Jesus and Blasco, 2011; Bernardes de Jesus et al., 2011; Bernardes de 
Jesus B, 2012). Interestingly, global downregulation of Sox4 mRNA in Sox4lox/lox mice also 
resulted in a reduced incidence of spontaneous cancer, indicating that Sox4 is necessary 
for tumour development and providing genetic evidence for previous reports 
demonstrating oncogenic activity of Sox4 and its requirement for cellular transformation 
(Penzo-Mendez, 2010; Vervoort et al., 2013b). Further connections of Sox4 with ageing 
and its impact in cancer were obtained recently, when an inverse correlation of Sox4 
expression with age and p16 mRNA levels was observed in mouse lungs and this was 
proposed to function as an anti-tumour mechanism in small cell lung carcinoma onset 
(Castillo et al., 2012). 
 
 
III. Role of Sox4 in skin homeostasis and regeneration 
 
Sox4 is the only SoxC class member whose expression has been detected by in 
developing hair follicles (Dy et al., 2008). Moreover, during normal hair cycling, expression 
of Sox4 was observed in the hair progeny during anagen (proliferative), but not during 
telogen (resting) phase (Lowry et al., 2005). To gain deeper knowledge into the 
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consequences of Sox4 abrogation in adult tissues, we generated mice conditionally 
deleted for Sox4 in the skin (Sox4cKO mice). We expected a dramatic skin condition, in a 
similar fashion to deletion of other Sox factors expressed in skin such as Sox9, which is 
also induced during morphogenesis (Nowak et al., 2008). We found a moderate increase 
in skin atrophy and hyperpigmentation in our hypomorphic Sox4 mouse model (Table 3). 
However, we did not see any overt defects in skin stratification and mice displayed a 
largely normal hair coat upon gross examination. Nonetheless, the tail skin 
hyperpigmentation phenotype that we previously observed in Sox4lox/lox mice was 
incremented upon full Sox4 abrogation. After close examination of Sox4cKO mouse skin, 
we detected decreased proliferation, concomitant with accumulation of short telomeres 
and DNA damage and senescence/ageing markers such as p16 and p19 at the tail skin 
epidermis. These results reinforced the pro-ageing phenotype that we detected upon 
global downregulation of Sox4 in the whole organism in hypomorphic mice.  
Decreased mean telomere length and accumulation of short telomeres have been 
previously observed to happen in a progressive manner in ageing mouse tail skin (Flores 
et al., 2008). Moreover, reduced telomere length limits the regenerative potential of skin 
stem cells (Flores et al., 2006; Flores et al., 2005), and this has obvious implications in the 
accelerated onset of ageing (Donate and Blasco, 2011). The striking longer telomere 
length observed in Sox4cKO mice hair bulge (the main skin stem cell niche in tail skin) is 
suggestive of decreased replicative history in HFSCs, likely reflecting stem cell resistance 
to activation cues  and thus accounting for the accelerated ageing seen in the most 
differentiated parts of the skin (Flores et al., 2008). If this hypothesis was true, we should 
expect a deteriorated response of HFSCs upon forced proliferation cues in the absence of 
Sox4. Indeed, when we performed hair plucking to compel entry into hair cycle, we saw 
specific upregulation of Sox4, indicating likely a role for this protein during hair 
regeneration; moreover, Sox4 depletion resulted in delayed, but not abrogated, wound 
healing and hair coat regeneration. We also detected accumulation of DNA damage at 
stem cell compartments and decreased proliferation in Sox4-depleted skin undergoing 
plucking-induced regeneration. 
It has been largely demonstrated that accumulation of DNA damage is one of the 
driving forces of ageing, and one of its bona fide molecular biomarkers (Hoeijmakers, 
2009; Lopez-Otin et al., 2013). DNA damage accumulates naturally with age, thus limiting 
stem cell function (Sharpless and DePinho, 2007); the proof that accumulation of DNA 
damage leads to accelerated ageing arises from engineered mouse models with 
deficiencies in distinct DNA repair pathways, that show accelerated ageing due to a faster 
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stem cell decline (Schumacher et al., 2008). Age-dependent stem cell dysfunction seems 
to be one of the major determinants in mammalian lifespan regulation due to the 
accelerated loss of the regenerative capacity of somatic tissues (Lombard et al., 2005; 
Signer and Morrison, 2013). We have observed an exacerbated DNA damage 
accumulation at stem cell compartments upon induction of forced proliferation with 
plucking (Figure 22), likely indicating replication stress sensitivity, in line with previous 
reports showing an XRCC1-dependent sensitivity to DNA damage and subsequent 
γH2AX  accumulation in Sox4 depleted cells (Chetty et al., 2012). We can hypothesize on 
the other hand that the accumulation of DNA damage could be indicative of ageing due to 
defective stem cell activation and tissue maintenance. As we have detected increased 
γH2AX staining in both resting tail skin (thus indicating a persistent accumulation of DNA 
damage likely due to stem cell dysfunction and subsequent accelerated ageing) but also 
in the short-term, right after induction of proliferation of HFSCs upon plucking (thus 
probably indicating increased sensitivity to RS), we cannot rule out either of the 
hypothesis, but assume that they act in a concerted manner to contribute to accelerated 
ageing in skin depleted of Sox4. 
 
In order to further dissect the molecular mechanisms causing accelerated ageing, 
DNA damage accumulation and hampering stem cell activation, we performed microarray-
based transcriptional profiling of WT and cKO mice undergoing hair regeneration. We 
validated our microarray by confirming downregulation in a Sox4 signature and 
downregulation of known Sox4 target genes. 
We then analysed the gene set enrichment by using the NCI, Reactome and 
KEGG repositories; we observed a notable downregulation in a number of cell cycle and 
DNA repair pathways in Sox4-deficient skin undergoing regeneration. This confirms the 
previously observed resistance to induction of proliferation and accumulation of DNA 
damage by IHC (Figure 22). On one hand, the cell cycle-inducing abilities of Sox4 have 
been broadly demonstrated, in the context of cancer cell biology (Bilir et al., 2013; Cai et 
al., 2011; Yu et al., 2013). On the other hand, the marked downregulation in DNA damage 
repair pathways in the face of γH2AX accumulation could underline an inefficient DDR in 
the absence of Sox4, therefore leading to accumulation of unrepaired DNA. There are 
reports demonstrating that Sox4 is induced upon DNA damage in an ATM/ATR-
dependent pathway (Pan et al., 2009); however in this context the authors found a striking 
tumour-suppressive function for Sox4 in mediating p53 stabilization, inducing apoptosis 
and preventing cell cycle entry. Other groups have found similar accumulation of Sox4 
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upon genotoxic agents, associated however in this case to radiation-resistance and linked 
to p53 downregulation; in fact, Sox4-depleted cells spontaneously accumulate DNA 
damage and are extremely sensitive to IR (Chetty et al., 2012). In light of these and our 
results, we propose a model in which Sox4 can be activated to alleviate this stress, and 
therefore its absence leads to accumulation of stress and blockade of cell cycle 
progression under certain situations, such as oncogenic or hair follicle stem cell activation 
(Figure 29).  
 
 
Oncogenes
Stem Cell
Activation
Cancer
Homeostasis
ProliferationStress
Sox4
Figure 29. Model for Sox4-mediated 
alleviation of stress to promote cell
cycle progression under oncogenic 
or replicative stresses, and its impact
in cancer and homeostasis.
 
 
 
Interestingly, we also observed a significant downregulation of pathways related to 
HFSC activity, such as Myc and Hedgehog (Kobielak et al., 2007; Watt et al., 2008). We 
further confirmed a defective HFSC activation specific to hair plucking-induced hair 
regeneration by testing a list of genes which have been recently linked to Wnt-activated β-
catenin-sensitive plucking-induced transcriptional program. According to this work, Tcf3/4 
levels prevent HFSC activation and promote quiescence. When the Wnt pathway 
becomes activated β-catenin-mediated alleviation of the repression exerted by the Tcf3/4 
complex results in transcriptional activation of a subset of genes relevant for the initiation 
of hair follicle differentiation programs (Lien et al., 2014). The downregulation of these β-
catenin-sensitive Wnt targets reveals specific deficiencies in the overcome of the 
threshold that leads to HFSC activation in the absence of Sox4. Interestingly, Sox4 was 
itself one of such genes included in the Cttnb1-sensitive gene set (Figure 24), in 
agreement with our results showing Sox4 upregulation upon plucking (Figure 21) and 
previous results suggesting Sox4 upregulation as a result of hair follicle cycling-mediated 
Wnt/βcatenin activation (Lowry et al., 2005). In this regard, it has been also demonstrated 
that Wnt pathway induces Sox4 in several settings to promote tumorigenesis by 
modulating the Wnt transcriptional output (Bilir et al., 2013; Cai et al., 2011; Lai et al., 
2011; Lee et al., 2011). Nevertheless, the molecular mechanism by which Sox4 controls 
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Wnt/β-catenin signalling still remains poorly understood. There is a clear consensus 
claiming cooperation among the canonical Wnt pathway and Sox4, in contrast to other 
Sox members, such as Sox17. In the colon adenocarcinoma cell line SW480, Sox4 was 
shown to stimulate Wnt/β-catenin activity by preventing proteasomal degradation of β-
catenin through direct interaction with β-catenin and TCF/LEF factors (Sinner et al., 2007). 
A direct interaction with TCF4 has also been reported by independent studies, this time 
excluding direct interaction of Sox4 with β-catenin during morular differentiation of 
endometrial carcinomas (Saegusa et al., 2012). Others have attributed the Sox4-
dependent modulation of the Wnt pathway to the interaction of Sox4 with Plakoglobin; the 
formation of a Sox4-plakoglobin transcriptional complex in a Wnt3a-dependent manner 
induces direct transcriptional regulation of Wnt target genes such as Dicer and Axin2 
among others (Lai et al., 2011). In skin, Bmpr1 signalling blocks Wnt-mediated expression 
of Sox4 and this constitutes a threshold orchestrated by the dermal papilla to govern 
HFSC activation (Kobielak et al., 2007). All these results indicate a plethora of possibilities 
for Sox4-mediated regulation of and activation by Wnt signalling pathway. Regardless of 
the molecular mechanism, that can be highly variable depending on the cell of origin, the 
metabolic and/or the transformation status of such cells, it is clear that at least in skin 
Sox4 is induced upon Wnt cues and modulates its transcriptional output, likely by long-
range genomic interactions of Wnt-target promoters and Sox4-associated enhancers. 
We, in light of our microarray results and current published literature, propose a 
role for Sox4 in modulating the repression that Tcf3/4 exerts on Wnt targets in resting hair 
follicles. Upon stimulus that activate the HFSC to initiate proliferation and differentiation 
programs, Sox4 is induced to counterbalance Tcf3/4 repression and therefore favour β-
catenin-mediated activation of genes required for hair regeneration (Figure 30).  
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Active HFSCs
Transcriptional
Activation
Hair Follicle regeneration
Wnt/
β-cat
Figure 30. Modulation of Wnt/β-catenin output by Sox4 upon hair regeneration cues.
Sox4
 
 
Interestingly, very recent studies focused on the transcription factor C/EBPα (a 
major hub in myeloid lineage specific differentiation genes in the haematopoietic 
compartment) discovered that it is actually a direct repressor of Sox4 (Zhang et al., 2013), 
and this was shown to function as a preventive mechanism for uncontrolled proliferation, 
providing a molecular mechanism for the development of a specific subtype of myeloid 
leukemia (Fung et al., 2013). Besides its implication in tumour development, the authors 
also discovered that Sox4 is also required for normal haematopoiesis, and when depleted 
by means of shRNA in total bone marrow cells, there is a progressive loss of colony-
forming abilities along passages, an in vitro approach to model stem cell ageing. The 
authors did not go beyond this observation in studying stem cell maintenance, but these 
results clearly point out towards a requirement of Sox4 for long-term maintenance of 
competent adult stem cells, given that Sox4 depletion mimics stem cell ageing 
phenotypes. This goes in line with our own observations in skin, and suggesting a role for 
Sox4 in regulating somatic stem cells from a broad panel of tissues.  
 
Overall, Sox4 seem to modulate both HFSC activation and alleviation of DNA 
damage, and both pathways seem to be cross-wired as an adaptive solution to improve 
survival and tolerate moderate stress levels, at the cost of accelerating the oraganism 
decline (Rossi et al., 2007).  
 
Discussion 
 
 
 95
 
IV. Sox4 is required for chemically-induced skin carcinogenesis 
 
We observed that hypomorphic Sox4 mice are resistant to spontaneous cancer 
onset. This appreciation goes in line with a general reduction of Sox4 levels in this mouse 
model, and provides genetic evidence that highlights the requirement of Sox4 for cellular 
transformation. Most studies showing the implication of Sox4 in cancer have vastly 
demonstrated that Sox4 is indeed sufficient for achieving transformation, either alone or in 
combination with additional pro-oncogenic insults (Vervoort et al., 2013b). However, our 
results suggest that Sox4 expression can constitute a key event during the acquisition of a 
malignant phenotype. We further proved that by means of conditional ablation of Sox4 in 
skin. We demonstrated that not only upon intrinsic cues, but also during multistep 
chemically-induced carcinogenesis, absence of Sox4 correlates with resistance to cell 
transformation. This can be explained by a decrease in proliferation, as observed both at 
early time points after TPA treatment and at benign skin lesions (papilloma). The interest 
of proving the oncogenic effects of Sox4 in skin stems also from the fact that Sox4 has 
been detected overexpressed in most types of tumours; however non-melanoma skin 
cancer is largely disregarded in these studies (Vervoort et al., 2013b). Of note, elevated 
Sox4 levels associated to stratified epithelial-type cancer, such as squamous cell 
carcinoma (SCC) from different tissues, displays good correlation with disease 
progression as ascertained from cancer databases such as Oncomine (Figure 31). 
 
 
Figure 31. Relative Sox4 expression levels in esophageal SCC (left, dark blue) and head and neck SCC (right, 
dark blue) compared to normal tissue (light blue). Source: Oncomine.  
 
We have demonstrated that abrogation of Sox4 prevents skin carcinogenesis. The 
diminished cell transformation is probably due to the resistance to respond to proliferation-
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inducing agents, as assessed by reduced Ki67 staining after short or long-term treatment 
with TPA. This phenotype parallels the delay in hair regeneration and induction of hair 
cycling upon hair plucking, as shown by of hair coat regeneration dynamics, IHC and 
transcriptional profiling. Therefore, Sox4 provides a connection between the processes 
involved in stem cell activation and cancer development. In support of that hypothesis, 
most of the DEGs that we found in our microarray of skin undergoing regeneration are 
linked to cancer, further reinforcing the interconnection of stem cell activation with cancer. 
In this regard, a recent report showing contribution of mobilized Sox4-positive, activated 
HFSC owing to E6/E7 oncoprotein activity suggests an intimate connection between 
HFSC activation, Sox4-positive progeny and skin tumorigenesis (da Silva-Diz et al., 
2013). In this context, a resistance to HFSC activation could act as a preventive barrier to 
the onset of cellular transformation. However, there are a number of reports showing a 
connection of Sox4 with the acquisition of pro-invasive features typical of EMT, and 
therefore usually linked to metastatic colonization of distant tissues rather than a 
prevention in the initial steps of epithelial carcinogenesis (Parvani and Schiemann, 2013; 
Vervoort et al., 2013a; Wang et al., 2013). Nonetheless, there are other reports showing 
how Bmpr1 abrogation can lead to deregulated expression of a panel of genes associated 
to the Wnt signalling pathway, among which they found Sox4. This resulted in loss of the 
quiescence signalling in the niche, but not in the HFSC, leading to the appearance of 
tumour-like cysts reminiscent of pylomatrichoma lesions in humans (Kobielak et al., 2007). 
Therefore we cannot but assume that Sox4 influences carcinogenesis both at early and 
late stages of cellular transformaction and metastatic colonization.  
Finally, an interesting side-observation linked Sox4 to melanomagenesis in the 
course of the TPA/DMBA assays. While all the treated mice developed melanocytic 
lesions during the 15-week TPA treatment, Sox4-reduced contexts such as Sox4cKO, 
Sox4lox/lox, and Sox4HET mice bore increased number of them from the beginning (not 
shown). When we stopped the TPA treatment to assess tumour dependence on 
proliferative cues, we observed progressive disappearance of such lesions in SoxWT mice, 
but not in the rest of genotypes. In fact, they even increased in size and number, and we 
even detected a metastatic melanoma in the lymph nodes of a Sox4HET mouse. As 
mentioned before, melanoma is the only type of tumour in which reduced Sox4 levels 
seem to be detrimental for tumour prognosis and disease progression, in conflict with the 
observations in all other types of tumours, in which the roles of Sox4 pinpoint it definitely 
as an oncogene. Nevertheless, these paradoxical appreciations cannot be consistently 
reproduced even in studies arising from the same research groups and to our eyes is a 
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reflection of the paradigmatic intrinsic heterogeneity of this type of tumours, that hampers 
tumour stratification according to common genetic somatic events (Curtin et al., 2005). It 
is tempting to speculate that absence of Sox4 can wire a transcriptional program relevant 
for melanoma malignization without promoting transformation in this cell context, and that 
in certain situation such as p16 loss, this pre-malignant setting can turn the melanocytic 
benign nevi into metastatic melanoma (Figure 32).  
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Transformation
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Figure 32. Model for the postulated sequence of events that coonects Sox4 loss with the onset of melanoma.  
 
 
In this regard, recent studies show that SPARC (secreted peptide acidic and rich in 
cystein), a protein involved in matrix remodelling and a natural cellular inhibitor of Sox4 
(Coskunpinar et al., 2013; Chiodoni et al., 2010), has opposing roles to Sox4 in most 
tumours and its overexpression usually leads to apoptosis, while its loss is associated with 
disease progression and radioresistance, as expected (Chetty et al., 2012; Said et al., 
2013). Interestingly, melanoma constitutes an exception to this precept, and SPARC is 
usually increased during melanoma progression in contrast to Sox4, and its depletion 
prevents cancer cell growth (Maloney et al., 2009), in support for a negative role for Sox4 
in this specific type of cancer, whose origins still remain to be investigated 
 
 
 
Our results, overall, show that Sox4 is an important factor in modulating the pace 
of somatic stem cell activation. Its deletion leads to delayed stem cell activation and 
regeneration of damaged tissues, without excessively compromising their integrity. Its 
permanent ablation or reduced levels can lead to accelerated ageing and loss of normal 
tissue homeostasis; however, the most notable effect of Sox4 deletion is the acquired 
resistance to chemical skin carcinogenesis. So far, Sox4 had been studied in depth in the 
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context of most tumour types but non-melanoma skin cancer. Our results suggest that the 
inhibition of Sox4 could prove useful in preventing the expansion of malignant cells, and 
our new mouse model contributes to a better understanding of the in vivo roles of Sox4 in 
adult tissues in organ homeostasis, cancer and ageing.  
  
 
 
 
 
 
 
 
Conclusiones
“(…)  
—Más o menos —concedió Oliveira—. Es increíble lo que te cuesta 
captar las nociones abstractas. Unidad, pluralidad... ¿No sos capaz de 
sentirlo sin necesidad de ejemplos? No, no sos capaz. En fin, vamos a 
ver: tu vida, ¿es una unidad para vos? 
—No, no creo. Son pedazos, cosas que me fueron pasando. (…)”. 
 
Julio Cortázar. Rayuela, Cap 19 
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1. Sox4 se sobreexpresa durante la diferenciación de células madre embrionarias y se 
reprime durante la generación de iPS. Sin embargo, Sox4 es dispensable para la 
generación de iPS y para la diferenciación a todas las capas embrionarias. 
 
2. Los ratones Sox4lox/lox con expresión reducida de Sox4 en todos sus tejidos constituyen 
el primer modelo de ratón con niveles de Sox4 globalmente reducidos en todo el 
organismo adulto. 
 
3. Los ratones Sox4lox/lox nacen en ratios sub-mendelianos; la expresión reducida de Sox4 
correlaciona con síntomas de envejecimiento acelerado tales como adiposidad 
disminuida, fallo hepático crónico, fragilidad ósea y reducción de la supervivencia. 
Estos ratones presentan telómeros cortos y son resistentes al cáncer espontáneo.  
 
4. La eliminación condicional de Sox4 en epitelio estratificado no altera a la correcta 
estratificación de la piel pero aumenta la frecuencia de hiperpigmentación y disminuye 
la proliferación y el grosor epidérmico.  
 
5. La eliminación de Sox4 genera envejecimiento prematura de la piel con reducción de 
longitud telomérica, acumulación de p53/p16/p19 y daño en el DNA en la IFE de la piel 
de cola. Los telómeros alargados en el compartimento de células madre de la piel 
sugieren mayor quiescencia en ausencia de Sox4. 
 
6. Sox4 se induce con la depilación de forma específica y secuencial. La ausencia de 
Sox4 resulta en la acumulación de daño en el DNA y menor proliferación de 
keratinocitos, generando un retraso en la regeneración del pelaje. La ausencia de 
Sox4 también causa retraso en el cierre de heridas. 
  
7. La ausencia de Sox4 genera desregulación específica de genes relacionados con las 
vías de ciclo celular, respuesta a daño en el DNA y Myc/Hedgehog/Wnt, durante la 
regeneración del pelo post-depilatoria.  
 
8. La expresión de Sox4 es necesaria para la carcinogénesis química y su ausencia 
reduce la incidencia de tumores y aumenta la resistencia a transformación celular. Por 
el contrario, el número de lesiones melanocíticas aumenta, sugiriendo un papel para 
dicha proteína en melanomagenesis. 
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Conclusions 
“(…) se entrara por una puerta cualquiera a un jardín cualquiera, a un 
jardín alegórico para los demás, como los mandalas son alegóricos para 
los demás (…) a lo mejor todo eso no era más que una nostalgia del  
paraíso terrenal, un ideal de pureza, solamente que la pureza venía a ser 
un producto inevitable de la simplificación, (…)”. 
 
Julio Cortázar. Rayuela, Cap 18 
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1. Sox4 is overexpressed during mES differentiation and repressed during iPS 
reprogramming. Sox4 expression is dispensable for the generation of iPS cells and 
differentiation into all the embryonic layers. 
 
2. Hypomorphic Sox4lox/lox mice, bearing decreased Sox4 mRNA across tissues 
constitute the first viable mouse model with globally-reduced Sox4 expression in the 
adulthood. These mice are viable and fertile. 
 
3. Sox4lox/lox mice are born at sub-mendelian ratios; reduced Sox4 levels result in a 
premature onset of age-associated pathologies such as reduced adiposity, chronic 
hepatic failure, bone frailty and reduced lifespan. These mice also bear short 
telomeres and are cancer-resistant.  
 
4. Conditional ablation of Sox4 in stratified epithelia results in normal skin stratification 
but increased skin hyperpigmentation, reduced proliferation and epidermal thinning.  
 
5. Sox4 abrogation causes premature skin ageing, as evidenced by shortened 
telomeres, accumulation of p53, p16/p19 mRNA and DNA damage in tail skin IFE. 
Longer telomeres at the HFSC compartment are suggestive of increased 
quiescence in the absence of Sox4. 
 
6. Sox4 mRNA is specifically induced after plucking in a stepwise manner. Hair 
depilation in a Sox4-depleted context results in DNA damage accumulation and 
reduced proliferation in skin keratinocytes, resulting in delayed hair coat 
regeneration. Sox4 depletion also results in a slowed-down wound healing. 
 
7. Sox4 depletion correlates with a specific downregulation of cell cycle, DNA damage 
response and Myc/Hedgehog/Wnt pathways, as assessed by microarray profiling, 
during plucking-induced hair regeneration.  
 
8. Expression of Sox4 is required for chemical skin carcinogenesis and its absence 
results in strongly reduced tumour burden, and resistance to cell transformation in 
vitro. The number and size of melanocytic lesions are increased in Sox4-reduced 
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contexts upon DMBA/TPA treatment, suggesting a role for this protein in 
melanomagenesis. 
  
 
 
 
 
 
 
 
References 
 
"(…) La melancolía de una vida demasiado corta para tantas 
bibliotecas. Cuando creés que has aprehendido plenamente cualquier 
cosa, la cosa lo mismo que un iceberg tiene un pedacito por fuera y te 
lo muestra, y el resto enorme está más allá de tu límite.(…)". 
 
Julio Cortázar. Rayuela, Cap 84 
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